Back to GetFilings.com



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

 

   

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

   

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2003

     

Commission file number 001-09913

 

KINETIC CONCEPTS, INC.

(Exact name of registrant as specified in its charter)


Texas

74-1891727

(State of Incorporation)

(I.R.S. Employer Identification No.)



8023 Vantage Drive
San Antonio, Texas 78230
Telephone Number: (210) 524-9000
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)




Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes _  No _X  

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes _  No _X  

 

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

 

Common Stock:   71,122,556 shares as of July 21, 2003

TABLE OF CONTENTS



PART I - FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS

                   Condensed Consolidated Balance Sheets

                   Condensed Consolidated Statements of Earnings

                   Condensed Consolidated Statements of Cash Flows

                   Notes to Condensed Consolidated Financial Statements 

ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4.     CONTROLS AND PROCEDURES



PART II - OTHER INFORMATION

ITEM 1.     LEGAL PROCEEDINGS

ITEM 4.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

ITEM 5.     OTHER INFORMATION

ITEM 6.     EXHIBITS AND REPORTS ON FORM 8-K

SIGNATURES

 

 

 

 

 

 

 

 

 

 

Table of Contents

KINETIC CONCEPTS, INC.


INDEX

 

Page No.

PART I.

FINANCIAL INFORMATION

 4

Item 1.

Financial Statements

 4

Condensed Consolidated Balance Sheets

 4

Condensed Consolidated Statements of Earnings

 5

Condensed Consolidated Statements of Cash Flows

 6

Notes to Condensed Consolidated Financial Statements

 7

     Parent Company Balance Sheet, June 30, 2003

15

     Parent Company Balance Sheet, December 31, 2002

16

     Parent Company Statement of Earnings, three months ended June 30, 2003

17

     Parent Company Statement of Earnings, three months ended June 30, 2002

18

     Parent Company Statement of Earnings, six months ended June 30, 2003

19

     Parent Company Statement of Earnings, six months ended June 30, 2002

20

     Parent Company Statement of Cash Flows, six months ended June 30, 2003

21

     Parent Company Statement of Cash Flows, six months ended June 30, 2002

22

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

49

Item 4.

Controls and Procedures

49

PART II.

OTHER INFORMATION

50

Item 1.

Legal Proceedings

50

Item 4.

Submission of Matters to a Vote of Security Holders

50

Item 5.

Other Information

50

Item 6.

Exhibits and Reports on Form 8-K

51

SIGNATURES

52

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS

KINETIC CONCEPTS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

June 30,  

December 31,

2003      

2002      

(unaudited) 

Assets:

Current assets:

   Cash and cash equivalents

$  102,973 

$    54,485 

   Accounts receivable, net

159,695 

152,896 

   Accounts receivable - other

175,000 

   Inventories, net

33,771 

37,934 

   Prepaid expenses and other current assets

11,745 

9,760 

_______ 

_______ 

          Total current assets

308,184 

430,075 

_______ 

_______ 

Net property, plant and equipment

123,995 

105,549 

Loan issuance cost, less accumulated amortization

    of $13,107 in 2003 and $11,949 in 2002

4,753 

5,911 

Goodwill

48,796 

46,357 

Other assets, less accumulated amortization of

    $7,145 in 2003 and $6,840 in 2002

30,287 

30,167 

_______ 

_______ 

$ 516,015 

$ 618,059 

_____ 

_____ 

Liabilities and Shareholders' Deficit:

Current liabilities:

   Accounts payable

$    12,377 

$    11,156 

   Accrued expenses

79,732 

61,556 

   Current installments of long-term obligations

13,939 

30,550 

   Current installments of capital lease obligations

151 

157 

   Derivative financial instruments

1,914 

1,341 

   Income taxes payable

34,897 

14,615 

   Current deferred income taxes

66,838 

_______ 

_______ 

          Total current liabilities

143,010 

186,213 

_______ 

_______ 

Long-term obligations, net of current installments

394,737 

491,300 

Capital lease obligations, net of

   current installments

19 

95 

Deferred income taxes, net

7,475 

9,501 

Deferred gain, sale of headquarters facility

9,503 

10,023 

Other noncurrent liabilities

213 

1,363 

_______ 

_______ 

554,957 

698,495 

Shareholders' deficit:

_______ 

_______ 

   Common stock; issued and outstanding 71,123

       in 2003 and 70,928 in 2002

71 

71 

   Retained deficit

(39,425)

(76,216)

   Accumulated other comprehensive income (loss)

412 

(4,291)

_______ 

_______ 

(38,942)

(80,436)

_______ 

_______ 

$ 516,015 

$ 618,059 

_____ 

_____ 

See accompanying notes to condensed consolidated financial statements.

 

Table of Contents

KINETIC CONCEPTS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Earnings

(in thousands, except per share data)
(unaudited)

Three months ended

Six months ended    

June 30,           

June 30,          

2003  

2002  

2003  

2002  

Revenue:

   Rental and service

$ 140,854 

$ 107,595 

$ 270,296 

$ 209,010 

   Sales and other

41,611 

29,513 

78,753 

55,239 

_______ 

_______ 

_______ 

_______ 

         Total revenue

182,465 

137,108 

349,049 

264,249 

_______ 

_______ 

_______ 

_______ 

Rental expenses

87,499 

66,625 

166,459 

128,415 

Cost of goods sold

14,713 

11,764 

28,358 

21,369 

_______ 

_______ 

_______ 

_______ 

         Gross profit

80,253 

58,719 

154,232 

114,465 

Selling, general and administrative expenses

44,489 

32,571 

85,395 

63,763 

_______ 

_______ 

_______ 

_______ 

         Operating earnings

35,764 

26,148 

68,837 

50,702 

Interest income

347 

99 

747 

109 

Interest expense

(8,050)

(10,384)

(16,228)

(20,692)

Foreign currency gain

2,368 

2,992 

4,156 

2,448 

 

_______ 

 

_______ 

 

_______ 

 

_______ 

         Earnings before income taxes

30,429 

 

18,855 

 

57,512 

 

32,567 

               

Income taxes

11,411 

 

7,259 

 

21,567 

 

12,538 

 

_______ 

 

_______ 

 

_______ 

 

_______ 

         Net earnings

$  19,018 

 

$  11,596 

 

$  35,945 

 

$  20,029 

 

_____ 

 

_____ 

 

_____ 

 

____ 

               

         Basic earnings per common share

$       0.27 

 

$       0.16 

 

$       0.51 

 

$       0.28 

 

_____ 

 

_____ 

 

_____ 

 

_____ 

         Diluted earnings per common

             

           share

$       0.25 

 

$       0.15 

 

$       0.47 

 

$       0.26 

 

_____ 

 

_____ 

 

_____ 

 

_____ 

         Average common shares:

             

             Basic (weighted average

             

             outstanding shares)

71,070 

 

70,926 

 

71,032 

 

70,926 

_____ 

 

_____ 

 

_____ 

 

_____ 

             Diluted (weighted average

             

             outstanding shares)

77,236 

 

77,683 

 

76,904 

 

77,688 

 

_____ 

 

_____ 

 

_____ 

 

_____ 

               

See accompanying notes to condensed consolidated financial statements.

 

Table of Contents

KINETIC CONCEPTS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

       Six months ended
        June 30,

 

2003  

 

2002  

Cash flows from operating activities:

   Net earnings

$  35,945 

$  20,029 

   Adjustments to reconcile net earnings to net cash

      provided by operating activities:

         Depreciation

20,529 

15,486 

         Amortization

1,462 

2,177 

         Provision for uncollectible accounts receivable

3,527 

4,861 

         Amortization of deferred gain on sale/leaseback of

            headquarters facility

(521)

         Change in assets and liabilities net of effects from

            purchase of subsidiaries and unusual items:

               Increase in accounts receivable, net

(10,342)

(20,580)

               Decrease in other accounts receivable

175,000 

               Decrease (increase) in inventories

4,148 

(498)

               Increase in prepaid expenses and other current assets

(1,979)

(851)

               Increase in accounts payable

1,218 

1,039 

               Increase (decrease) in accrued expenses

18,100 

(4,331)

               Increase in income taxes payable

20,282 

7,952 

               Decrease in current deferred income taxes

(66,838)

               Decrease in deferred income taxes, net

(1,826)

(1,357)

_______ 

_______ 

                  Net cash provided by operating activities

198,705 

23,927 

_______ 

_______ 

Cash flows from investing activities:

   Additions to property, plant and equipment

(34,381)

(30,500)

   Decrease (increase) in inventory to be converted into

      equipment for short-term rental

(1,300)

1,100 

   Dispositions of property, plant and equipment

634 

1,799 

   Business acquisitions, net of cash acquired

(2,224)

(3,596)

   Increase in other assets

(425)

(1,172)

_______ 

_______ 

                  Net cash used by investing activities

(37,696)

(32,369)

_______ 

_______ 

Cash flows from financing activities:

   Proceeds from (repayment of) notes payable, long term capital lease and

      other obligations

(114,856)

17,088 

   Proceeds from exercise of stock options

846 

_______ 

_______ 

                  Net cash provided (used) by financing activities

(114,010)

17,096 

_______ 

_______ 

Effect of exchange rate changes on cash and cash equivalents

1,489 

515 

_______ 

_______ 

Net increase in cash and cash equivalents

48,488 

9,169 

Cash and cash equivalents, beginning of period

54,485 

199 

_______ 

_______ 

Cash and cash equivalents, end of period

$102,973 

$   9,368 

_____ 

_____ 

Supplemental disclosure of cash flow information:

   Cash paid during the first six months for:

      Interest

$   14,903 

$  19,526 

      Income taxes

$   69,392 

$    9,756 

See accompanying notes to condensed consolidated financial statements.

Table of Contents

KINETIC CONCEPTS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

(1)     SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a)     Basis of Presentation

      The financial statements presented herein include the accounts of Kinetic Concepts, Inc., together with our consolidated subsidiaries ("KCI"). The unaudited condensed consolidated financial statements appearing in this quarterly report on Form 10-Q should be read in conjunction with the financial statements and notes thereto included in KCI's latest annual report on Form 10-K. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, financial position and cash flows in conformity with accounting principles generally accepted in the United States. Operating results from interim periods are not necessarily indicat ive of results that may be expected for the fiscal year as a whole. In our opinion, the consolidated financial statements reflect all adjustments considered necessary for a fair presentation of our results for the periods presented. Certain reclassifications of amounts related to the prior year have been made to conform with the 2003 presentation.

(b)     Stock Options

      We use the intrinsic value method in accounting for our stock option plan. In the first six months of 2003 and 2002, compensation costs of approximately $1.7 million and $340,000, respectively, net of estimated taxes, have been recognized in the financial statements related to this plan. If the compensation cost for our stock-based employee compensation plan had been determined based upon a fair value method consistent with Statement of Financial Accounting Standards No. 123 ("SFAS 123"), "Accounting for Stock-Based Compensation," our net earnings and earnings per share would have been decreased to the pro forma amounts indicated below. For purposes of pro forma disclosures, the estimated fair value of the options is recognized as an expense over the options' respective vesting periods. Our pro forma calculations are as follows (dollars in thousands, except for earnings per share information):

Three months ended
   June 30

Six months ended
   June 30,

2003  

2002   

2003  

2002   

Net earnings as reported

$  19,018 

$   11,596 

$  35,945 

$  20,029 

Pro forma net earnings

$  18,617 

$   11,225 

$  35,170 

$  19,295 

Earnings per share as reported

   Basic earnings per common share

$      0.27 

$      0.16 

$      0.51 

$     0.28 

   Diluted earnings per common share

$      0.25 

$      0.15 

$      0.47 

$     0.26 

Pro forma earnings per share

   Basic earnings per common share

$      0.26 

$      0.16 

$      0.50 

$     0.27 

   Diluted earnings per common share

$      0.24 

$      0.14 

$      0.46 

$     0.25 

      We are not required to apply, and have not applied, the method of accounting prescribed by SFAS 123 to stock options granted prior to January 1, 1995. Moreover, the pro forma compensation cost reflected above may not be representative of future expense.

Table of Contents

(c)     Other New Accounting Pronouncements

      In June 2001, the Financial Accounting Standards Board, or ("FASB") issued SFAS 143, "Accounting for Asset Retirement Obligations," effective for fiscal years beginning after June 15, 2002. This standard addresses financial accounting and reporting obligations associated with the retirement of tangible long-lived assets and the associated asset retirement costs. The standard requires us to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred and to adjust its present value in each subsequent period. In addition, we must capitalize an amount equal to the adjustment by increasing the carrying amount of the related long-lived asset, which is depreciated over the remaining useful life of the related asset. We adopted SFAS 143 during the first quarter of 2003 and it did not have a significant effect on our financial position or results of operations.

      In January 2003, the FASB issued Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities," effective for fiscal years or interim periods beginning after June 15, 2003. FIN 46 addresses accounting for, and disclosure of, variable interest entities. FIN 46 requires the disclosure of the nature, purpose and exposure of any loss related to our involvement with variable interest entities. We adopted the provisions of FIN 46 for post January 31, 2003 variable interest entities during the first quarter of 2003 and it did not have a significant effect on our financial position or results of operations. We continue to evaluate the potential effects of the consolidation provisions of FIN 46 that will be adopted during the quarter ended September 30, 2003.

      Specifically, we are evaluating the beneficial ownership of two Grantor Trusts which we acquired in December 1996 and December 1994. The assets held by each Trust consist of a McDonnell Douglas DC-10 aircraft and three engines. In connection with the acquisitions, KCI paid cash of $7.2 million and $7.6 million, respectively. The Trusts held debt of $48.4 million and $51.8 million, respectively, which is non-recourse to KCI. The DC-10 aircraft are leased to the Federal Express Corporation through June 2012 and January 2012, respectively. Federal Express pays monthly rent to a third party who, in turn, pays the entire amount to the holders of the non-recourse indebtedness, which is secured by the aircraft. The holder's recourse in event of a default is limited to the Trusts assets.

      In April 2003, the FASB issued Statement of Financial Accounting Standards No. 149 (SFAS 149), "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." This statement amends SFAS 133 to provide clarification on the financial accounting and reporting of derivative instruments and hedging activities and requires contracts with similar characteristics to be accounted for on a comparable basis. We do not expect the adoption of SFAS 149, which will be effective for contracts entered into or modified after June 30, 2003, to have a material effect on our financial condition or results of operations.

      On May 15, 2003, the FASB issued SFAS 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." The statement established standards for classifying and measuring as liabilities certain financial instruments that embody obligations of the issuer and have characteristics of both liabilities and equity. SFAS 150 must be applied immediately to instruments entered into or modified after May 31, 2003. We have adopted SFAS 150 and have determined it will not have a material impact on our financial position or results of operations.

(d)     Other Significant Accounting Policies

      For further information, see Note 1 to the consolidated financial statements included in KCI's Annual Report on Form 10-K for the year ended December 31, 2002.

 

Table of Contents

(2)      ACQUISITIONS

      On May 23, 2003, we acquired all of the outstanding capital stock of MedClaim Inc., a North Carolina corporation, for approximately $2.2 million in cash, net of cash acquired, and other consideration of $450,000. MedClaim Inc. processed Medicare Part B insurance claims for us and continues to act in that capacity. The operating results of MedClaim Inc. did not have a material impact, and we do not anticipate that the acquisition will have a material impact, on KCI's results of operations.

 

(3)      ACCOUNTS RECEIVABLE COMPONENTS

      Accounts receivable consist of the following (dollars in thousands):

June 30, 

December 31,

2003   

2002   

Trade accounts receivable:

   Facilities / dealers

$    98,464 

$    91,756  

   Third party payers:

      Medicare / Medicaid

34,103 

31,721  

      Managed care, insurance and other

57,647 

53,229  

_______ 

_______  

190,214 

176,706  

Medicare V.A.C. receivables prior to

   October 1, 2000

14,191 

14,351  

Employee and other receivables

1,784 

2,410  

_______ 

_______  

206,189 

193,467  

Less:  Allowance for doubtful accounts

(32,303)

(26,220) 

         Allowance for Medicare V.A.C. receivables

             prior to October 1, 2000         

(14,191)

(14,351) 

_______ 

_______  

$  159,695 

$  152,896  

_____ 

_____ 

 

(4)      INVENTORY COMPONENTS

      Inventories are stated at the lower of cost (first-in, first-out) or market (net realizable value). Inventories are comprised of the following (dollars in thousands):

June 30, 

December 31,

2003    

2002    

Finished goods

$    14,400 

$   16,411   

Work in process

2,792 

2,411   

Raw materials, supplies and parts

31,598 

31,825   

______ 

______   

48,790 

50,647   

Less: Amounts expected to be converted

           into equipment for short-term rental

(12,400)

(11,100)   

        Reserve for excess and obsolete

           inventory

(2,619)

(1,613)   

______ 

______   

$    33,771 

$   37,934   

_____ 

_____   

 

 

Table of Contents

(5)      LONG-TERM OBLIGATIONS AND DERIVATIVE FINANCIAL INSTRUMENTS

      Long-term obligations consist of the following (dollars in thousands):

June 30, 

December 31,

2003    

2002    

Senior Credit Facility:

    Term loans:

       Tranche A due 2003

$   11,742 

$   27,500   

       Tranche B due 2004

57,068 

85,500   

       Tranche C due 2005

57,068 

85,500   

       Tranche D due 2006

62,470 

93,575   

       Tranche E due 2005

19,878 

29,775   

    Revolving bank credit facility

           - 

            -   

_______ 

______   

208,226 

321,850   

9 5/8% Senior Subordinated

    Notes due 2007

200,000 

200,000   

MedClaims note payable

450 

-   

_______ 

______   

408,676 

521,850   

Less current installments

(13,939)

(30,550)  

_______ 

______   

$ 394,737 

$  491,300   

______ 

______   

      In January 2003, we received $175 million pursuant to the settlement of our antitrust lawsuit with Hillenbrand Industries (see Note 9 for additional discussion). The cash received, net of approximately $66 million of income taxes and approximately $2 million of fees and expenses, was used to pay down $107 million of indebtedness on the senior credit facility.

      As of June 30, 2003, we had no revolving loans outstanding. However, we had outstanding five letters of credit in the aggregate amount of $10.9 million. The resulting availability under the revolving credit facility was $39.1 million at the end of the quarter.

Interest Rate Protection

      We follow SFAS 133, "Accounting for Derivative Instruments and Hedging Activities," and its amendments, SFAS 137 and 138, in accounting for our derivative instruments. SFAS 133 requires that all derivative instruments be recorded on the balance sheet at fair value. We have designated our interest rate swap agreements as cash flow hedge instruments. The swap agreements are used to manage exposure to interest rate movement by effectively changing the variable interest rate to a fixed rate. The critical terms of the interest rate swap agreements and the interest-bearing debt associated with the swap agreements must be the same to qualify for the shortcut method of accounting. Changes in the effective portion of the fair value of the interest rate swap agreement will be recognized in other comprehensive income, net of tax effects, until the hedged item is recognized into earnings.

      The following chart summarizes interest rate hedge transactions effective during the first six months of 2003 (dollars in thousands):

Nominal

Fixed

Accounting Method

Effective Dates

Amount

Interest Rate

Status  

Shortcut

12/31/02 - 12/31/03

$     80,000 

1.745%

Outstanding

Shortcut

12/31/02 - 12/31/04

$   100,000 

2.375%

Outstanding

      As of December 31, 2002, two $100 million interest rate swap agreements were in effect to take advantage of low interest rates. On January 31, 2003, we sold $20 million of our $100 million, 1.7450% interest rate swap effective March 31, 2003 which resulted in an expense of approximately

Table of Contents

$74,000 which was recorded in the first quarter of 2003. As of June 30, 2003, the current interest rate swap agreements effectively fix the base-borrowing rate on 86% of our variable rate debt. The fair value of these swaps at inception was zero. Due to subsequent movements in interest rates, as of June 30, 2003, the fair values of the $80 million and $100 million swap agreements were negative and were adjusted to reflect a liability of approximately $300,000 and $1.6 million, respectively. As a result of interest rate protection agreements in effect during the first six months of 2003 and 2002, we recorded interest expense of approximately $770,000 and $1.3 million, respectively. (See Note 8.)

 

(6)      EARNINGS PER SHARE

      The following table sets forth the reconciliation from basic to diluted average common shares and the calculations of net earnings per common share. Net earnings for basic and diluted calculations do not differ (dollars in thousands, except per share data): (See Note 1 (b).)

   Three months ended
   June 30,

   Six months ended
   June 30,

2003  

2002   

2003 

2002   

Net earnings

$   19,018 

$   11,596 

$   35,945 

$ 20,029 

______ 

______ 

______ 

______ 

Average common shares:

   Basic (weighted-average outstanding shares)

71,070 

70,926 

71,032 

70,926 

   Dilutive potential common shares from stock options

6,166 

6,757 

5,872 

6,762 

______ 

______ 

______ 

______ 

   Diluted (weighted-average outstanding shares)

77,236 

77,683 

76,904 

77,688 

____ 

____ 

____ 

____ 

Basic earnings per common share

$      0.27 

$      0.16 

$      0.51 

$      0.28 

____ 

____ 

____ 

____ 

Diluted earnings per common share

$      0.25 

$      0.15 

$      0.47 

$      0.26 

____ 

____ 

____ 

____ 

 

(7)       STOCK PLANS

      In May 2003, our Board of Directors approved the 2003 Non-Employee Directors Stock Plan (the "Directors Stock Plan"). Grants under this plan shall be made to non-employee directors of the company. The maximum aggregate number of shares of Common Stock that may be issued in connection with grants under the Directors Stock Plan is 400,000 shares, subject to adjustment as provided for in the plan. The exercise price of options granted under this plan is determined as the fair market value, as determined by our Board of Directors, of the shares of the Company's common stock on the date that such option is granted. The options granted will vest and become exercisable incrementally over a period of three years. The right to exercise an option shall terminate seven years after the grant date, unless sooner as provided for in the plan. The Directors Stock Plan is administered by a committee of the Board of Directors.

 

Table of Contents

(8)      OTHER COMPREHENSIVE INCOME

      The components of other comprehensive income are as follows (dollars in thousands):

 

Three months ended  
June 30,          

2003 

2002 

Net earnings

$ 19,018 

$ 11,596 

Foreign currency translation adjustment

3,747 

4,238 

Net derivative loss, net of taxes of $206 in 2003

    and $394 in 2002

(383)

(732)

Reclassification adjustment for losses included in

    income, net of taxes of $129 in 2003 and $206 in 2002

238 

383 

Reclassification adjustment for loss recognized on termination

    of interest rate swap, net of taxes of $70 in 2002

(130)

_____ 

_____ 

    Other comprehensive income

$ 22,620 

$ 15,355 

____ 

____ 

 

Six months ended     
June 30,            

2003 

2002 

Net earnings

$  35,945 

$  20,029 

Foreign currency translation adjustment

5,076 

3,492 

Net derivative loss, net of taxes of $470 in 2003

    and $194 in 2002

(874)

(361)

Reclassification adjustment for losses included in

    income, net of taxes of $270 in 2003 and $438 in 2002

501 

813 

Reclassification adjustment for loss recognized on termination

    of interest rate swap, net of taxes of $148 in 2002

(258)

_____ 

_____ 

    Other comprehensive income

$  40,648 

$  23,715 

____ 

____ 

      The earnings associated with certain of our foreign affiliates are considered to be permanently invested and no provision for U.S. federal and state income taxes on these earnings or translation adjustments has been made.

      As of June 30, 2003, derivative financial instruments valued at a liability of $1.9 million were recorded as a result of our adoption of SFAS 133, "Accounting for Derivative Instruments and Hedging Activities." This liability is based upon the valuation of our interest rate protection agreements associated with our Senior Credit Facility. (See Note 5.)

 

 

Table of Contents

(9)      COMMITMENTS AND CONTINGENCIES

      During the fourth quarter of 2002, we recorded a gain from the settlement of an antitrust lawsuit with Hillenbrand Industries, Inc. and Hill-Rom Company, Inc., a wholly-owned subsidiary of Hillenbrand (together, "Hillenbrand"). Under the settlement, Hillenbrand agreed to pay KCI $250 million in two payments. In January 2003, we received the first installment of $175 million pursuant to the settlement. Net of fees and expenses of $1.7 million, this transaction added $173.3 million of pretax income and $106.4 million of net income to the 2002 fourth quarter results. The cash received, net of approximately $66 million of income taxes and approximately $2 million in fees and expenses, was used to pay down $107 million of indebtedness on the senior credit facility. Hillenbrand will pay to KCI an additional $75 million in January 2004, subject to certain conditions. No accrual has been made related to this payment.

      Other than commitments for new product inventory, including disposable "for sale" products of $16.9 million, we have no material long-term capital commitments.

 

(10)      SEGMENT AND GEOGRAPHIC INFORMATION

      We are principally engaged in the rental and sale of innovative therapeutic devices and systems throughout the United States and in 15 primary countries internationally.

      We define our business segments based on geographic management responsibility. We have two reportable segments: USA, which includes operations in the United States, and International, which includes operations for all international units. We measure segment profit as operating earnings, which is defined as income before interest income or expense, foreign currency gains and losses and income taxes. All intercompany transactions are eliminated in computing revenue, operating earnings and assets. The prior years have been made to conform with the 2003 presentation. Information on segments and a reconciliation of consolidated totals are as follows (dollars in thousands):

Three months ended

Six months ended

June 30,

June 30,

2003   

2002   

2003   

2002   

Revenue:

   USA

$ 137,631 

$ 106,022 

$ 264,840 

$ 205,377 

   International

44,834 

31,086 

84,209 

58,872 

_______ 

_______ 

_______ 

_______ 

         Revenue

$ 182,465 

$ 137,108 

$ 349,049 

$ 264,249 

_____ 

_____ 

_____ 

_____ 

Operating Earnings:

   USA

$  47,213 

$  33,056 

$  91,735 

$  65,139 

   International

6,657 

4,572 

11,104 

8,648 

   Other (1):

      Executive

(5,316)

(3,151)

(9,339)

(4,958)

      Finance

(5,051)

(3,907)

(9,924)

(7,578)

      Manufacturing/Engineering

(1,102)

(1,570)

(2,259)

(3,659)

      Administration

(6,637)

(2,852)

(12,480)

(6,890)

_______ 

_______ 

_______ 

_______ 

         Total Other

(18,106)

(11,480)

(34,002)

(23,085)

_______ 

_______ 

_______ 

_______ 

            Operating earnings

$  35,764 

$  26,148 

$  68,837 

$  50,702 

_____ 

_____ 

_____ 

_____ 

  1. Other includes general headquarter expenses which are not allocated to the individual
    segments and are included in selling, general and administrative expenses within our
    Condensed Consolidated Statements of Earnings.

Table of Contents

(11)      SUBSEQUENT EVENT

      On July 11, 2003, we announced that we entered into a commitment letter with Morgan Stanley Senior Funding, Inc. and Credit Suisse First Boston for a new senior secured credit facility. The new facility would be composed of a $480 million term loan and a $100 million revolving credit facility. We expect to borrow $480 million under the new term loan facility and to use the proceeds from the new credit facility as part of a recapitalization of KCI, which is expected to result in the redemption of all of our outstanding 9 5/8% Senior Subordinated Notes Due 2007 and the repayment of outstanding indebtedness under our existing credit facility. The closing of the new credit facility is expected to occur in mid-August 2003, but is subject to a number of important conditions. There can be no assurance that these conditions will be satisfied or that the terms described above will not change.

 

(12)      GUARANTOR CONDENSED CONSOLIDATING FINANCIAL STATEMENTS

      In November of 1997, Kinetic Concepts, Inc. issued $200 million in subordinated debt securities to finance a tender offer to purchase certain of our common shares outstanding. In connection with the issuance of these securities, certain of our wholly owned subsidiaries (the "guarantor subsidiaries") act as guarantors. Certain other subsidiaries (the "non-guarantor subsidiaries") do not guarantee the debt. The guarantor subsidiaries are wholly owned by KCI and the guarantees are full, unconditional, joint and several. We have not presented separate financial statements and other disclosures concerning the Subsidiary Guarantors because management has determined that such information is not material to investors.

      Our indebtedness under the existing senior credit facility is guaranteed by certain of our subsidiaries and is secured by a first priority security interest in (1) all of our tangible and intangible assets and those of our domestic subsidiaries (subject to certain customary exceptions), including, without limitation, intellectual property and real estate owned by us and our subsidiaries, and (2) substantially all shares of capital stock and intercompany debt of each of our present and future subsidiaries (limited in the case of certain foreign subsidiaries to 65% of the voting stock of such entity). The senior credit facility contains covenants which, among other things, limit the incurrence of additional indebtedness, investments, dividends, loans and advances, capital expenditures, transactions with affiliates, asset sales, acquisitions, mergers and consolidations, prepayments of other indebtedness, liens and encumbrances and other matters customarily restricted in such agreements. The net assets of the guarantor subsidiaries are detailed on the following tables.

      The following tables present the condensed consolidating balance sheets of Kinetic Concepts, Inc. as a parent company, our guarantor subsidiaries and our non-guarantor subsidiaries as of June 30, 2003 and December 31, 2002 and the related condensed consolidating statements of earnings for the three and six-month periods ended June 30, 2003 and 2002, and the condensed consolidating statements of cash flows for the six-month periods ended June 30, 2003 and 2002, respectively.

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Balance Sheet

June 30, 2003

(in thousands)

(unaudited)

Kinetic

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

ASSETS:

Current assets:

   Cash and cash equivalents

$              - 

$    81,676 

$    21,297 

$               - 

$  102,973 

   Accounts receivable, net

129,682 

40,097 

(10,084)

159,695 

   Inventories, net

16,813 

16,958 

33,771 

   Prepaid expenses and other current assets

5,929 

5,816 

11,745 

________ 

________ 

________ 

________ 

________ 

          Total current assets

234,100 

84,168 

(10,084)

308,184 

________ 

________ 

________ 

________ 

________ 

Net property, plant and equipment

107,042 

30,779 

(13,826)

123,995 

Loan issuance cost, net

4,753 

4,753 

Goodwill

41,205 

7,591 

48,796 

Other assets, net

31,527 

20,260 

(21,500)

30,287 

Intercompany investments and advances

(38,195)

423,847 

8,038 

(393,690)

________ 

________ 

________ 

________ 

________ 

         

$  (38,195)

$ 842,474 

$ 150,836 

$ (439,100)

$ 516,015 

_____ 

_____ 

_____ 

______ 

_____ 

LIABILITIES AND SHARE-

HOLDERS EQUITY (DEFICIT):

Current liabilities:

   Accounts payable

$             - 

$      7,894 

$      4,483 

$               - 

$    12,377 

   Accrued expenses

747 

63,092 

15,893 

79,732 

   Current installments of long-

       term obligations

13,939 

13,939 

   Current installments of capital

       lease obligations

151 

151 

   Intercompany payables

23,788 

(23,788)

   Derivative financial instruments

1,914 

1,914 

   Income taxes payable

32,301 

2,596 

34,897 

________ 

________ 

________ 

________ 

________ 

          Total current liabilities

747 

143,079 

22,972 

(23,788)

143,010 

________ 

________ 

________ 

________ 

________ 

Long-term obligations, net of

    current installments

394,737 

394,737 

Capital lease obligations, net of current

    installments

16 

19 

Intercompany payables, non current

(21,500)

21,500 

Deferred income taxes, net

7,596 

(121)

7,475 

Deferred gain, sale of headquarters facility

9,503 

9,503 

Other noncurrent liabilities

21,713 

(21,500)

213 

________ 

________ 

________ 

________ 

________ 

          

747 

555,131 

44,488 

(45,409)

554,957 

Shareholders' equity (deficit)

(38,942)

287,343 

106,348 

(393,691)

(38,942)

________ 

________ 

________ 

________ 

________ 

          

$  (38,195)

$ 842,474 

$ 150,836 

$ (439,100)

$ 516,015 

_____ 

_____ 

_____ 

______ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And
Parent Company Balance Sheet
December 31, 2002
(in thousands)

Kinetic

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

ASSETS:

Current assets:

   Cash and cash equivalents

$             - 

$    41,185 

$    13,300 

$               - 

$    54,485 

   Accounts receivable, net

125,106 

35,612 

(7,822)

152,896 

   Accounts receivable - other

175,000 

175,000 

   Inventories, net

20,113 

17,821 

37,934 

   Prepaid expenses and other

      current assets

6,377 

3,383 

9,760 

________ 

________ 

________ 

________ 

________ 

          Total current assets

175,000 

192,781 

70,116 

(7,822)

430,075 

Net property, plant and equipment

96,458 

23,516 

(14,425)

105,549 

Loan issuance cost, net

5,911 

5,911 

Goodwill

38,724 

7,633 

46,357 

Other assets, net

31,420 

20,247 

(21,500)

30,167 

Intercompany investments and advances

(187,076)

508,045 

23,447 

(344,416)

________ 

________ 

________ 

________ 

________ 

$ (12,076)

$ 873,339 

$ 144,959 

$ (388,163)

$ 618,059 

______ 

______ 

______ 

______ 

______ 

LIABILITIES AND SHARE-

HOLDERS' EQUITY (DEFICIT):

Current liabilities:

   Accounts payable

$             - 

$      4,632 

$      6,524 

$               - 

$    11,156 

   Accrued expenses

1,522 

46,058 

13,976 

61,556 

   Current installments of long-

      term obligations

30,550 

30,550 

   Current installments of capital

      lease obligations

157 

157 

   Intercompany payables

22,497 

(22,497)

   Derivative financial instruments

1,341 

1,341 

   Income taxes payable

8,615 

6,000 

14,615 

   Current deferred income taxes

66,838 

66,838 

________ 

________ 

________ 

________ 

________ 

          Total current liabilities

68,360 

113,850 

26,500 

(22,497)

186,213 

________ 

________ 

________ 

________ 

________ 

Long-term obligations, net of

   current installments

491,300 

491,300 

Capital lease obligations,

   net of current installments

75 

20 

95 

Intercompany payables, noncurrent

(21,500)

21,500 

Deferred income taxes, net

9,251 

250 

9,501 

Deferred gain, sale of headquarters facility

10,023 

10,023 

Other noncurrent liabilities

22,863 

(21,500)

1,363 

________ 

________ 

________ 

________ 

________ 

          

68,360 

625,862 

48,020 

(43,747)

698,495 

Shareholders' equity (deficit)

(80,436)

247,477 

96,939 

(344,416)

(80,436)

________ 

________ 

________ 

________ 

________ 

 

$ (12,076)

$ 873,339 

$ 144,959 

$ (388,163)

$ 618,059 

______ 

______ 

______ 

______ 

______ 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Earnings

For the three months ended June 30, 2003

(in thousands)

(unaudited)

Kinetic

Historical

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

REVENUE:

Rental and service

$           - 

$  110,928 

$   29,926 

$             - 

$ 140,854 

Sales and other

32,994 

14,890 

(6,273)

41,611 

_______ 

________ 

________ 

________ 

_______ 

      Total revenue

143,922 

44,816 

(6,273)

182,465 

_______ 

________ 

________ 

________ 

_______ 

Rental expenses

59,894 

27,605 

87,499 

Cost of goods sold

12,820 

5,099 

(3,206)

14,713 

_______ 

________ 

________ 

________ 

_______ 

      Gross profit

71,208 

12,112 

(3,067)

80,253 

Selling, general and administrative

   expenses

40,366 

4,123 

44,489 

_______ 

________ 

________ 

________ 

_______ 

      Operating earnings

30,842 

7,989 

(3,067)

35,764 

Interest income

331 

16 

347 

Interest expense

(8,050)

(8,050)

Foreign currency gain

2,022 

346 

2,368 

_______ 

________ 

________ 

________ 

_______ 

      Earnings before income

         taxes and equity in

         earnings of subsidiaries

25,145 

8,351 

(3,067)

30,429 

Income taxes

10,312 

2,248 

(1,149)

11,411 

_______ 

________ 

________ 

________ 

________ 

      Earnings before equity

         in earnings of subsidiaries

14,833 

6,103 

(1,918)

19,018 

      Equity in earnings of subsidiaries

19,018 

6,102 

(25,120)

_______ 

________ 

________ 

________ 

________ 

      Net earnings

$ 19,018 

$  20,935 

$    6,103 

$ (27,038)

$    19,018 

____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Earnings

For the three months ended June 30, 2002

(in thousands)

(unaudited)

Kinetic

Historical

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

REVENUE:

Rental and service

$           - 

$   86,757 

$   20,838 

$           - 

$   107,595 

Sales and other

25,068 

10,456 

(6,011)

29,513 

______ 

______ 

______ 

______ 

______ 

      Total revenue

111,825 

31,294 

(6,011)

137,108 

______ 

______ 

______ 

______ 

______ 

Rental expenses

47,810 

18,815 

66,625 

Cost of goods sold

11,736 

3,950 

(3,922)

11,764 

______ 

______ 

______ 

______ 

______ 

      Gross profit

52,279 

8,529 

(2,089)

58,719 

Selling, general and administrative

   expenses

29,584 

2,987 

32,571 

______ 

______ 

______ 

______ 

______ 

      Operating earnings

22,695 

5,542 

(2,089)

26,148 

Interest income

19 

80 

99 

Interest expense

(10,384)

(10,384)

Foreign currency gain (loss)

3,024 

(32)

2,992 

______ 

______ 

______ 

______ 

______ 

      Earnings before income

         taxes and equity in

         earnings of subsidiaries

15,354 

5,590 

(2,089)

18,855 

Income taxes

6,075 

1,988 

(804)

7,259 

______ 

______ 

______ 

______ 

______ 

      Earnings before equity in

         earnings of subsidiaries

9,279 

3,602 

(1,285)

11,596 

      Equity in earnings of subsidiaries

11,596 

3,602 

(15,198)

______ 

______ 

______ 

______ 

______ 

      Net earnings

$   11,596 

$   12,881 

$    3,602 

$  (16,483)

$   11,596 

_____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Earnings

For the six months ended June 30, 2003

(in thousands)

(unaudited)

Kinetic

Historical

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

REVENUE:

Rental and service

$           - 

$  214,078 

$   56,218 

$           - 

$   270,296 

Sales and other

64,311 

27,941 

(13,499)

78,753 

________ 

________ 

________ 

________ 

________ 

      Total revenue

278,389 

84,159 

(13,499)

349,049 

________ 

________ 

________ 

________ 

________ 

Rental expenses

114,151 

52,308 

166,459 

Cost of goods sold

25,958 

9,626 

(7,226)

28,358 

________ 

________ 

________ 

________ 

________ 

      Gross profit

138,280 

22,225 

(6,273)

154,232 

Selling, general and administrative

   expenses

76,621 

8,774 

85,395 

________ 

________ 

________ 

________ 

________ 

      Operating earnings

61,659 

13,451 

(6,273)

68,837 

Interest income

670 

77 

747 

Interest expense

(16,228)

(16,228)

Foreign currency gain

3,544 

612 

4,156 

________ 

________ 

________ 

________ 

________ 

      Earnings before income

         taxes and equity in

         earnings of subsidiaries

49,645 

14,140 

(6,273)

57,512 

Income taxes

20,106 

3,813 

(2,352)

21,567 

________ 

________ 

________ 

________ 

________ 

      Earnings before equity in

         earnings of subsidiaries

29,539 

10,327 

(3,921)

35,945 

      Equity in earnings of subsidiaries

35,945 

10,326 

(46,271)

________ 

________ 

________ 

________ 

________ 

      Net earnings

$  35,945 

$    39,865 

$   10,327 

$  (50,192)

$   35,945 

_____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Earnings

For the six months ended June 30, 2002

(in thousands)

(unaudited)

Kinetic

Historical

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

REVENUE:

Rental and service

$           - 

$  169,507 

$   39,503 

$           - 

$   209,010 

Sales and other

46,687 

19,738 

(11,186)

55,239 

________ 

________ 

________ 

________ 

________ 

      Total revenue

216,194 

59,241 

(11,186)

264,249 

________ 

________ 

________ 

________ 

________ 

Rental expenses

92,983 

35,432 

128,415 

Cost of goods sold

21,399 

7,034 

(7,064)

21,369 

________ 

________ 

________ 

________ 

________ 

      Gross profit

101,812 

16,775 

(4,122)

114,465 

Selling, general and administrative

   expenses

58,104 

5,659 

63,763 

________ 

________ 

________ 

________ 

________ 

      Operating earnings

43,708 

11,116 

(4,122)

50,702 

Interest income

21 

88 

109 

Interest expense

(20,692)

(20,692)

Foreign currency gain (loss)

2,559 

(111)

2,448 

________ 

________ 

________ 

________ 

________ 

      Earnings before income

         taxes and equity in

         earnings of subsidiaries

25,596 

11,093 

(4,122)

32,567 

Income taxes

10,341 

3,784 

(1,587)

12,538 

________ 

________ 

________ 

________ 

________ 

      Earnings before equity in

         earnings of subsidiaries

15,255 

7,309 

(2,535)

20,029 

      Equity in earnings of subsidiaries

20,029 

7,309 

(27,338)

________ 

________ 

________ 

________ 

________ 

      Net earnings

$  20,029 

$    22,564 

$    7,309 

$  (29,873)

$   20,029 

_____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Cash Flows

For the six months ended June 30, 2003

(in thousands)

(unaudited)

Kinetic

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

Cash flows from operating activities:

Net earnings

$    35,945 

$    39,865 

$    10,327 

$  (50,192)

$     35,945 

Adjustments to reconcile net earnings to net

   cash provided by operating activities

71,441 

46,566 

(3,122)

47,875 

162,760 

________ 

________ 

________ 

________ 

________ 

Net cash provided by operating

   activities

107,386 

86,431 

7,205 

(2,317) 

198,705 

_______ 

_______ 

_______ 

_______ 

_______ 

Cash flows from investing activities:

   Additions to property, plant and

      equipment

(20,121)

(13,949)

(311)

(34,381)

   Increase in inventory to be converted into

      equipment for short-term rental

(1,300)

(1,300)

   Dispositions of property, plant and

      equipment

410 

224 

634 

   Businesses acquisitions, net of cash

      acquired

(2,224)

-  

(2,224)

   Increase in other assets

(454)

29 

(425)

_______ 

_______ 

_______ 

_______ 

_______ 

Net cash used by investing

   activities

(23,689)

(13,696)

(311) 

(37,696)

_______ 

_______ 

_______ 

_______ 

_______ 

Cash flows from financing activities:

   Repayments of notes payable, long-term,

      capital lease and other obligations

(114,852)

(4)

(114,856)

   Proceeds from the exercise of stock options

846 

846 

   Proceeds from (repayments of)

      intercompany investments and advances

(112,936)

95,816 

15,485 

1,635 

   Other

4,704 

(3,215)

(993)

(496)

_______ 

_______ 

_______ 

_______ 

_______ 

Net cash provided (used) by financing

   activities

(107,386)

(22,251)

14,488 

1,139 

(114,010)

_______ 

_______ 

_______ 

_______ 

_______ 

Effect of exchange rate changes on

   cash and cash equivalents

1,489 

1,489 

_______ 

_______ 

_______ 

_______ 

_______ 

Net increase in cash and

   cash equivalents

40,491 

7,997 

48,488 

Cash and cash equivalents,

   beginning of period

41,185 

13,300 

54,485 

_______ 

_______ 

_______ 

_______ 

_______ 

Cash and cash equivalents, end

   of period

$              - 

$  81,676 

$   21,297 

$              -

$  102,973 

_____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

Condensed Consolidating Guarantor, Non-Guarantor And

Parent Company Statement of Cash Flows

For the six months ended June 30, 2002

(in thousands)

(unaudited)

Kinetic

Concepts,

Reclassi-

Kinetic

Inc.

Non-

fications

Concepts,

Parent

Guarantor

Guarantor

and

Inc.

Company

Sub-

Sub-

Elimi-

and Sub-

Borrower

sidiaries

sidiaries

nations

sidiaries

Cash flows from operating activities:

Net earnings

$     20,029 

$    22,564 

$     7,309 

$  (29,873)

$   20,029 

Adjustments to reconcile net earnings

   to net cash provided by operating

   activities

(20,029)

6,961 

(3,864)

20,830 

3,898 

________ 

________ 

________ 

________ 

________ 

Net cash provided by operating

   activities

29,525 

3,445 

(9,043)

23,927 

________ 

________ 

________ 

________ 

________ 

Cash flows from investing activities:

   Additions to property, plant and

      equipment

(19,694)

(11,815)

1,009 

(30,500)

   Decrease in inventory to be converted

      into equipment for short-term rental

1,100 

1,100 

   Dispositions of property, plant and

      equipment

1,130 

669 

1,799 

   Business acquisitions, net of cash

      acquired

(3,596)

(3,596)

   Increase in other assets

(737)

(435)

(1,172)

________ 

________ 

________ 

________ 

________ 

Net cash used by investing

   activities

(18,201)

(15,177)

1,009 

(32,369)

________ 

________ 

________ 

________ 

________ 

Cash flows from financing activities:

   Proceeds from notes payable, long-term,

      capital lease and other obligations

17,076 

12 

17,088 

   Proceeds from exercise of stock options

12 

(12)

   Proceeds (borrowings) on intercompany

      investments and advances

(5,691)

(21,698)

8,923 

18,466 

   Other

5,683 

(5,168)

5,330 

(5,845)

________ 

________ 

________ 

________ 

________ 

Net cash provided (used) by

   financing activities

(9,790)

14,265 

12,621 

17,096 

________ 

________ 

________ 

________ 

________ 

Effect of exchange rate changes on

   cash and cash equivalents

515 

515 

________ 

________ 

________ 

________ 

________ 

Net increase in cash and

   cash equivalents

1,534 

2,533 

5,102 

9,169 

Cash and cash equivalents,

   beginning of period

5,301 

(5,102)

199 

________ 

________ 

________ 

________ 

________ 

Cash and cash equivalents, end

   of period

$           - 

$   1,534 

$    7,834 

$          - 

$    9,368 

_____ 

_____ 

_____ 

_____ 

_____ 

 

Table of Contents

FORWARD LOOKING STATEMENTS

      This quarterly report on Form 10-Q contains forward-looking statements. When used in this report, the words "estimate," "project," "anticipate," "expect," "intend," "believe" and similar expressions are intended to identify forward-looking statements.

      All of the forward-looking statements contained in this report are based on estimates and assumptions made by the management of Kinetic Concepts, Inc. ("KCI," "we," "our" or "us"). These estimates and assumptions reflect our best judgment based on currently known market conditions and other factors. Although we believe such estimates and assumptions to be reasonable, they are inherently uncertain and involve risks and uncertainties beyond our control. In addition, management's assumptions about future events may prove to be inaccurate. Management cautions all readers that the forward-looking statements contained in this report are not guarantees of future performance and we cannot assure any reader that such statements will be realized. In all likelihood, actual results will differ from those contemplated by such forward-looking statements. Any such differences could result from a variety of factors, including the following:

          - foreign and domestic economic and business conditions;
          - demographic changes;
          - government regulations and changes in, or our failure to comply with, government
               regulations;

          - changes in the healthcare reimbursement policies of Medicare Part B or other governmental
               or private payers;

          - competition;
          - the loss of any significant customers;
          - our significant indebtedness;
          - our ability to effectively protect our intellectual property and not infringe on the intellectual
               property of others;
          - loss of any significant suppliers, especially sole-source suppliers;

          - failure of new products and services to achieve market acceptance;
          - liability resulting from litigation; and
          - other factors discussed elsewhere in this document and in our filings with the S.E.C.

 

Table of Contents

ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
                  AND RESULTS OF OPERATIONS

General

      Kinetic Concepts, Inc. is a global medical device company with leadership positions in (1) advanced wound care and (2) therapeutic surfaces which treat and prevent complications resulting from patient immobility. We design, manufacture, market and service a wide range of proprietary products which can significantly improve clinical outcomes while reducing the overall cost of patient care by accelerating the healing process or preventing complications. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings including acute care hospitals, extended care facilities and patients' homes both in the United States and abroad.

      Since the fourth quarter of 2000, our growth has been driven primarily by increased revenue from V.A.C. rentals and sales, which accounted for approximately 60.6% of total revenue in the first six months of 2003, up from approximately 50.6% in the first six months of 2002. We expect V.A.C. growth and the percentage of total revenue from V.A.C. rentals and sales to continue to increase, as it has in each of the last three years. Driven by continued market penetration, increased awareness and the introduction of two new V.A.C. systems in 2002, revenue for V.A.C. products and related services increased 60.0% from $244.5 million for the twelve months ended June 30, 2002 to $391.3 million for the twelve months ended June 30, 2003. Both the U.S. and international business segments contributed to this growth.

      We have direct operations in the United States, Canada, Europe, Australia and South Africa, and conduct additional business through distributors in Latin America, the Middle East and Asia. We manage our business in two geographical segments, our USA and International divisions. In the United States, which accounted for 76% of our revenue for the twelve months ended June 30, 2003, we have a substantial presence in all care settings. In acute and extended care, which accounted for more than half of our revenue, we bill our customers directly. In home care, where our revenue comes predominantly from V.A.C. products, we provide products and services directly to patients and bill third party payers, including Medicare and private insurance. Home care revenue is growing faster than the acute or extended care settings. For the twelve month period ended June 30, 2003, worldwide V.A.C revenue from the combined acute and extended care settings grew approxima tely 63% and V.A.C. revenue from the home care setting grew approximately 56% as compared to the twelve month period ended June 30, 2002. The home care market accounted for approximately 44% of V.A.C. business and approximately 26% of our total revenue for the twelve month period ended June 30, 2003. V.A.C. systems used in the home are reimbursed by both government insurance (Medicare and Medicaid) and private insurance and managed care organization payers.

      Internationally, substantially all of our revenue is generated from the acute care setting. A small amount of international V.A.C. revenue comes from home care. We expect this percentage to increase to the extent that we gain home care reimbursement for V.A.C. therapy.

      Our international operations are subject to foreign currency fluctuations. As a result, we establish and evaluate our business using a constant exchange rate by country. By using a constant exchange rate for comparing our current year activity with prior periods, we effectively eliminate from our operations the variances arising from foreign currency fluctuations. We refer to this internal analysis as revenue and expenses, on a constant exchange basis, throughout this report.

Table of Contents

Results of Operations

Second Quarter of 2003 Compared to Second Quarter of 2002

      The following table sets forth, for the periods indicated, the percentage relationship of each item to total revenue as well as the change in each line item as compared to the second quarter of the prior year (dollars in thousands):

Three Months Ended June 30,

Revenue Relationship

Variance         

2003  

2002  

Dollars 

Percent

Revenue:

  Rental and service

77 

%

78 

%

$  33,259 

30.9 

%

  Sales and other

23 

22 

12,098 

41.0 

____ 

____ 

_______ 

     Total revenue

100 

100 

45,357 

33.1 

Rental expenses

48 

49 

20,874 

31.3 

Cost of goods sold

2,949 

25.1 

____ 

____ 

_______ 

     Gross profit

44 

43 

21,534 

36.7 

Selling, general and administrative

     expenses

24 

24 

11,918 

36.6 

____ 

____ 

_______ 

     Operating earnings

20 

19 

9,616 

36.8 

Interest income

248 

nm 

Interest expense

(4)

(8)

2,334 

22.5 

Foreign currency gain (loss)

(624)

(20.9)

____ 

____ 

_______ 

     Earnings before income taxes

17 

13 

11,574 

61.4 

Income taxes

4,152 

57.2 

____ 

____ 

_______ 

     Net earnings

10 

%

%

$   7,422 

64.0 

%

___ 

___ 

_____ 

 

Table of Contents

Total Revenue:   Our revenue is divided between two primary operating segments: USA and International. The following table sets forth, for the periods indicated, the amount of revenue derived from each of these segments (dollars in thousands):

Three months ended June 30,

Variance           

        2003

     2002

Dollars  

   Percent

USA

  V.A.C.

     Rental

$     74,555 

$    49,572 

$    24,983 

50.4  

%

     Sales

19,855 

11,709 

8,146 

69.6  

_______ 

_______ 

_______ 

         Total V.A.C.

94,410 

61,281 

33,129 

54.1  

  Therapeutic surfaces/other

     Rental

36,373 

37,358 

(985)

(2.6) 

     Sales

6,848 

7,383 

(535)

(7.2) 

_______ 

_______ 

_______ 

         Total therapeutic surfaces/other

  43,221 

44,741 

(1,520)

(3.4)  

  Total USA rental

110,928 

86,930 

23,998

27.6  

  Total USA sales

26,703 

19,092 

7,611

39.9  

_______ 

_______ 

_______ 

       Subtotal - USA

$ 137,631 

$   106,022 

$  31,609 

29.8  

%

_______ 

_______ 

_______ 

International

  V.A.C.

     Rental

$      9,842 

$      4,618 

$     5,224 

113.1  

%

     Sales

9,181 

5,336 

3,845 

72.1  

_______ 

_______ 

_______ 

         Total V.A.C.

19,023 

9,954 

9,069 

91.1  

  Therapeutic surfaces/other

     Rental

20,084 

16,047 

4,037 

25.2  

     Sales

5,727 

5,085 

642 

12.6  

_______ 

_______ 

_______ 

         Total therapeutic surfaces/other

25,811 

21,132 

4,679 

22.1  

  Total International rental

29,926 

20,665 

9,261 

44.8  

  Total International sales

14,908 

10,421 

4,487 

43.1  

_______ 

_______ 

_______ 

       Subtotal - International

$   44,834 

$   31,086 

$  13,748 

44.2  

%

_______ 

_______ 

_______ 

  Total revenue

$ 182,465 

$ 137,108 

$  45,357 

33.1 

%

______ 

______ 

______ 

      Total revenue in the second quarter of 2003 increased $45.4 million, or 33.1%, from the prior-year period due primarily to increased demand for V.A.C. systems and related disposables. Rental revenue increased $33.3 million, or 30.9%, from the second quarter of 2002 while sales revenue increased $12.1 million, or 41.0%, compared to the prior-year period. Revenue growth in the second quarter of 2003 was driven by the launch of two new V.A.C. systems during 2002 along with enhanced V.A.C. sales and marketing efforts, which increased customer awareness of the benefits of V.A.C. therapy.

      Total domestic revenue for the second quarter of 2003 increased $31.6 million, or 29.8%, from the prior-year quarter due to increased usage of V.A.C. systems and related disposables. Domestic rental revenue in the second quarter of 2003 increased $24.0 million, or 27.6%, from the prior-year period and domestic sales revenue in the second quarter of 2003 increased $7.6 million, or 39.9%, from a year ago. The increases in domestic rental and sales revenue are due primarily to increased V.A.C. systems rentals resulting in increased demand for associated disposables, partially offset by a

Table of Contents

24.4% decrease in sales of vascular products and a 13.7% decrease in rentals in the extended care market. For the second quarter of 2003, average V.A.C. units out on rent increased 13.2% as compared to the first quarter of 2003 and increased 50.0% from the second quarter of 2002. Average rental price for the second quarter of 2003 was comparable with the first quarter of 2003 and also with the second quarter of 2002.

      Domestic V.A.C. revenue increased in the second quarter of 2003 by $33.1 million, or 54.1%, from the prior-year quarter due to an increase of both rental and sales revenue. V.A.C. rentals increased $25.0 million, or 50.4%, from the prior-year quarter. The increased rental revenue resulted from an increase in average units on rent per month of 50.0% for the the second quarter 2003 as compared to the second quarter 2002. Some managed care organizations pay an all-inclusive daily rate which covers the rental of V.A.C. systems and all needed disposables. All revenue associated with all-inclusive pricing is included in rental revenue. We are beginning to experience a shift away from all-inclusive pricing in the home care setting with third party payers. As we contract with these third party payers, our contracts are providing separate pricing for rental and disposable sale products versus the all-inclusive pricing previously used. Therefore, we have ex perienced, and expect to continue experiencing, a shift in revenue between the rental classification and the sales classification. V.A.C. sales increased in the second quarter of 2003 by $8.1 million, or 69.6%, from the prior-year quarter due to the shift in pricing methodology discussed above along with increased demand for V.A.C. disposables associated with increased V.A.C systems rentals. The cost of V.A.C. disposables, whether purchased through all-inclusive pricing or by itemized sale, is included in cost of goods sold.

      Domestic therapeutic surfaces/other revenue of $43.2 million for the second quarter of 2003 decreased $1.5 million, or 3.4%, from the prior-year quarter. Rental revenue from therapeutic surfaces/other declined approximately $1.0 million, or 2.6%, compared to the prior-year quarter as higher blended unit pricing of 3.1% in the acute, extended and home care markets was offset by a 7.7% lower unit volume in the combined extended and home care markets. Sales of vascular devices and dressings were down approximately $590,000, or 22.4%. The following table sets forth, for the periods indicated, the amount of revenue derived from each of our domestic care settings (dollars in thousands):

 

Three months ended June 30,

     

Variance      

Domestic therapeutic surfaces

2003  

2002  

Dollars 

Percent 

/other revenue

       
         

Acute/extended

$  38,698

$  39,773

$  (1,075)

(2.7)%

Home

2,563

2,456

107 

4.4    

Vascular-compression therapy

1,960

2,512

(552)

(22.0)   

 

_____

_____

___ 

 

   Total

$  43,221

$  44,741

$  (1,520)

(3.4)%

 

____

____

___ 

 

 

      The majority of our therapeutic surface business is generated in the hospital, or acute care, setting. Average acute care rental therapeutic surface units on rent per month remained essentially unchanged compared to the prior-year period, while average pricing increased slightly due primarily to product mix changes. Our acute care revenue is fueled by growth in our bariatric line. Extended care rental units decreased 17.3% due to lower overall Medicare Part A reimbursement in nursing homes and continued local and regional competition. Home care therapeutic surface revenue increased 4.4% from the prior-year comparable period due to a change in our revenue mix. We experienced increased sales of lower-therapy wound care therapeutic surface units, which, in turn, decreased the rental of therapeutic surfaces in the home care setting. Overall, the average number of domestic therapeutic surface rental units per month for the second quarter of 2003 declined 5.7% as compared to the prior period, but this decline was offset by a 3.1% price increase resulting from changes in our product mix.

Table of Contents

      Revenue from our international operating unit for the second quarter of 2003, including the favorable effects of foreign currency exchange rate fluctuations, increased $13.7 million, or 44.2%, over the prior-year period. The majority of our international revenue is generated in the acute care setting. International rental revenue increased $9.3 million, or 44.8%, from the prior-year period and sales revenue was up $4.5 million, or 43.1%, compared to the prior-year quarter. Favorable foreign currency exchange movements accounted for $6.6 million of the total international revenue increase when compared to the prior-year quarter. On a constant exchange basis, total international revenue increased $7.2 million, or 21.9%, from the prior-year period, rental revenue increased $4.8 million, or 22.2%, and sales revenue increased $2.3 million, or 21.4%. The rental revenue increase reflects a 57.5% increase in V.A.C. systems out on rent along with a 3.1% incr ease in therapeutic surface rental units in use, primarily in overlays. We also experienced improved rental pricing for our V.A.C. systems and therapeutic surfaces for the three months ended June 30, 2003 as compared to the same period of the prior year. The international sales increase was due to increased demand for V.A.C. systems and related disposables.

Rental Expenses:  Rental, or "field," expenses of $87.5 million for the second quarter of 2003 increased $20.9 million, or 31.3%, from $66.6 million in the prior-year period. The field expense increase was due primarily to increased labor, incentive compensation, parts, and product licensing expenses directly associated with the growth in V.A.C. therapy revenue. Of the $20.9 million variance in rental expenses for the second quarter of 2003, approximately $4.4 million resulted from foreign currency exchange movements. Field expenses for the second quarter of 2003 represented 62.1% of total rental revenue compared to 61.9% in the prior-year quarter.

Cost of Goods Sold:  Cost of goods sold of $14.7 million in the second quarter of 2003 increased $2.9 million, or 25.1%, from $11.8 million in the prior-year period due to increased sales of V.A.C. disposables. Sales margins increased to 64.6% in the second quarter of 2003 as compared to 60.1% in the prior-year period due to the shift away from all-inclusive pricing arrangements discussed above and cost reductions resulting from favorable pricing in our global supply contract for V.A.C. disposables entered into in December 2002.

Gross Profit:  Gross profit in the second quarter of 2003 increased approximately $21.5 million, or 36.7%, to $80.3 million from $58.7 million in the prior-year comparable quarter due primarily to the quarter-to-quarter increase in revenue resulting from increased demand for V.A.C. systems and related disposables. Gross profit margin in the second quarter of 2003 was 44.0%, up from 42.8% in the prior-year quarter due primarily to the increase in revenue discussed above.

Selling, General and Administrative Expenses:  Selling, general and administrative expenses increased $11.9 million, or 36.6%, to $44.5 million in the second quarter of 2003 from $32.6 million in the prior-year quarter. This increase was due primarily to an increase in variable costs associated with increased revenue from V.A.C. systems along with increases in insurance costs of $2.0 million and professional fees of $1.6 million. As a percentage of total revenue, selling, general and administrative expenses increased to 24.4% in the second quarter of 2003 as compared to 23.8% in the prior-year quarter.

Operating Earnings:  Operating earnings for the second quarter of 2003 increased $9.6 million, or 36.8%, to $35.8 million compared to the same period in 2002. The increase in operating earnings was directly attributable to the increase in revenue for the period, partially offset by higher operating costs and expenses. Operating margins for the second quarter of 2003, were 19.6%, up from 19.1% in the prior-year quarter, due to the increase in revenue without a corresponding increase in costs and expenses.

Table of Contents

Non-GAAP Measure:  We find earnings before interest expense, taxes and depreciation and amortization, or EBITDA, to be useful for measuring our ability to service our debt and our ability to generate cash for other purposes. EBITDA is a non-GAAP measure and should not be considered in isolation from, and is not intended to represent an alternative measure of, operating or net earnings or cash flow or any other measure of performance determined in accordance with GAAP. In addition, our definition of EBITDA is not necessarily comparable to similarly titled measures reported by other companies. The following table presents a reconciliation of EBITDA to net earnings, which we believe is the most directly comparable financial measure in accordance with accounting principles generally accepted in the United States ("GAAP") for the quarters ended June 30, 2003 and 2002 (dollars in thousands):

Three months ended   

June 30,

   2003

   2002

Net earnings

$  19,018 

$  11,596 

Interest expense

8,050 

10,384 

Depreciation and amortization (1)

10,747 

8,072 

Income taxes

11,411 

7,259 

______ 

______ 

        EBITDA

$ 49,226 

$ 37,311 

_____ 

_____ 

      (1) Excludes amortization of loan issuance costs, which is included in interest expense.

EBITDA for the second quarter of 2003 increased $11.9 million, or 31.9%, from the prior-year period due substantially to the change in operating earnings discussed above.

Interest Expense:  Interest expense in the second quarter of 2003 was $8.1 million compared to $10.4 million in the prior-year quarter. The interest expense decrease was due primarily to the partial paydown on our existing credit facility resulting from the $175 million litigation settlement payment received in January 2003. (See Notes 5 and 9 of Notes to Condensed Consolidated Financial Statements.)

Net Earnings:  Net earnings of $19.0 million for the second quarter of 2003 increased $7.4 million, or 64.0%, from the prior-year period due to the increase in operating earnings discussed above. Effective tax rates for the second quarter of 2003 and 2002 were 37.5% and 38.5%, respectively.

 

 

Table of Contents

Results of Operations

First Six Months of 2003 Compared to First Six Months of 2002

      The following table sets forth, for the periods indicated, the percentage relationship of each item to total revenue as well as the change in each line item as compared to the first six months of the prior year (dollars in thousands):

Six Months Ended June 30,

Revenue Relationship

Variance      

2003  

2002  

Dollars 

Percent

Revenue:

  Rental and service

77 

%

79 

%

$  61,286 

29.3 

%

  Sales and other

23 

21 

23,514 

42.6 

_______ 

_______ 

_______ 

     Total revenue

100 

100 

84,800 

32.1 

Rental expenses

48 

49 

38,044 

29.6 

Cost of goods sold

6,989 

32.7 

_______ 

_______ 

_______ 

     Gross profit

44 

43 

39,767 

34.7 

Selling, general and administrative

     expenses

24 

24 

21,632 

33.9 

_______ 

_______ 

_______ 

     Operating earnings

20 

19 

18,135 

35.8 

Interest income

638 

nm 

Interest expense

(5)

(8)

4,464 

21.6 

Foreign currency gain (loss)

1,708 

69.8 

_______ 

_______ 

_______ 

     Earnings before income taxes

16 

12 

24,945 

76.6 

Income taxes

9,029 

72.0 

_______ 

_______ 

_______ 

     Net earnings

10 

%

%

$  15,916 

79.5 

%

____ 

____ 

____ 

 

Table of Contents

Total Revenue:   Our revenue is divided between two primary operating segments: USA and International. The following table sets forth, for the periods indicated, the amount of revenue derived from each of these segments (dollars in thousands):

Six months ended June 30,

Variance          

        2003

     2002

Dollars  

  Percent 

USA

  V.A.C.

     Rental

$    139,843 

$    94,209 

$    45,634 

48.4  

%

     Sales

36,947 

21,702 

15,245 

70.2  

_______ 

_______ 

_______ 

         Total V.A.C.

176,790 

115,911 

60,879 

52.5  

  Therapeutic surfaces/other

     Rental

74,235 

75,618 

(1,383)

(1.8) 

     Sales

13,815 

13,848 

(33)

(0.2) 

_______ 

_______ 

_______ 

         Total therapeutic surfaces/other

   88,050 

89,466 

(1,416)

(1.6) 

  Total USA rental

214,078 

169,827 

44,251 

26.1  

  Total USA sales

50,762 

35,550 

15,212 

42.8  

_______ 

_______ 

_______ 

       Subtotal - USA

$ 264,840 

$  205,377 

$  59,463 

29.0  

%

_______ 

_______ 

_______ 

International

  V.A.C.

     Rental

$     17,660 

$      8,207 

$     9,453 

115.2  

%

     Sales

17,187 

9,611 

7,576 

78.8  

_______ 

_______ 

_______ 

         Total V.A.C.

34,847 

17,818 

17,029 

95.6  

  Therapeutic surfaces/other

     Rental

38,558 

30,976 

7,582 

24.5  

     Sales

10,804 

10,078 

726 

7.2  

_______ 

_______ 

_______ 

         Total therapeutic surfaces/other

49,362 

41,054 

8,308 

20.2  

  Total International rental

56,218 

39,183 

17,035 

43.5  

  Total International sales

27,991 

19,689 

8,302 

42.2  

_______ 

_______ 

_______ 

       Subtotal - International

$  84,209 

$   58,872 

$  25,337 

43.0  

%

_______ 

_______ 

_______ 

  Total revenue

$ 349,049 

$ 264,249 

$  84,800 

32.1  

%

______ 

______ 

______ 

      Total revenue in the first six months of 2003 increased $84.8 million, or 32.1%, from the prior-year period due primarily to increased demand for V.A.C. systems and related disposables. Rental revenue increased $61.3 million, or 29.3%, from the first six months of 2002 while sales revenue increased $23.5 million, or 42.6%, compared to the prior-year period. Revenue growth in the first six months of 2003 was driven by the launch of two new V.A.C. systems during 2002 along with enhanced V.A.C. sales and marketing efforts, which increased customer awareness of the benefits of V.A.C. therapy.

      Total domestic revenue for the first six months of 2003 increased $59.5 million, or 29.0%, from the prior-year period due to increased usage of V.A.C. systems and related disposables. Domestic rental revenue in the first six months of 2003 increased $44.3 million, or 26.1%, from the prior-year comparable period and domestic sales revenue in the first six months of 2003 increased $15.2 million, or 42.8%, from the prior-year period. The increase in total domestic revenue is due primarily to

Table of Contents

increased V.A.C. systems rentals resulting in increased demand for associated disposables, partially offset by a 27.2% decrease in sales of vascular products and a 11.3% decrease in rentals in the extended care market. V.A.C. units out on rent declined slightly in January 2003 due to a significant realignment of our domestic sales force. Since that time, demand for V.A.C. systems has increased steadily. For the six month period ended June 30, 2003, average V.A.C. units out on rent increased 50.9% as compared to the same period a year ago.

      Domestic V.A.C. revenue increased in the first six months of 2003 by $60.9 million, or 52.5%, from the prior-year period due to an increase of both rental and sales revenue. V.A.C. rentals increased $45.6 million, or 48.4%, from the prior-year period. The increased rental revenue resulted from an increase in average units on rent per month of 50.9% for the six-month period which was offset by a 1.6% decline in average rental price. Some managed care organizations pay an all-inclusive daily rate which covers the rental of V.A.C. systems and all needed disposables. All revenue associated with all-inclusive pricing is included in rental revenue. We are beginning to experience a shift away from all-inclusive pricing in the home care setting with third party payers. As we contract with these third party payers, our contracts are providing separate pricing for rental and disposable sale products versus the all-inclusive pricing previously used. Therefore , we have experienced, and expect to continue experiencing, a shift in revenue between the rental classification and the sales classification. V.A.C. sales increased $15.2 million, or 70.2%, from the prior-year period due to the shift in pricing methodology discussed above along with increased demand for V.A.C. disposables associated with increased V.A.C. systems rentals. The cost of V.A.C. disposables, whether purchased through all-inclusive pricing or by itemized sale, is included in cost of goods sold.

      Domestic therapeutic surfaces/other revenue of $88.1 million for the six month period ended June 30, 2003 decreased $1.4 million, or 1.6%, from the prior-year period, primarily due to a $1.3 million, or 25.5%, decrease in total vascular-compression therapy revenue. The following table sets forth, for the periods indicated, the amount of revenue derived from each of our domestic care settings (dollars in thousands):

 

Six months ended June 30,

     

Variance         

Domestic therapeutic surfaces

2003  

2002  

Dollars 

Percent 

/other revenue

       
         

Acute/extended

$  79,186

$  79,539

$     (353) 

(0.4) %

Home

5,014

4,759

255  

5.4     

Vascular-compression therapy

3,850

5,168

(1,318) 

(25.5)    

 

_____

_____

___  

 

   Total

$  88,050

$  89,466

$  (1,416) 

(1.6) %

 

____

____

___  

 

      The majority of our therapeutic surfaces/other business is generated in the hospital, or acute care, setting. Average acute care rental therapeutic surface units on rent per month remained essentially unchanged compared to the prior-year period, while average pricing increased 1.1% due primarily to product mix changes. Our acute care revenue is fueled by growth in our bariatric line. Extended care rental units decreased 18.0% due to lower overall Medicare Part A reimbursement in nursing homes and continued local and regional competition. Home care therapeutic surface revenue increased 5.4% from the prior-year comparable period due to a change in our revenue mix. We experienced increased sales of lower-therapy wound care therapeutic surface units, which, in turn, decreased the rental of therapeutic surfaces in the home care setting. Overall, the average number of domestic therapeutic surface rental units per month for the first six months of 2003 de clined 5.7% as compared to the prior-year period, but this decline was offset by a 4.1% price increase resulting from changes in our product mix.

      Revenue from our international operating unit for the first six months of 2003, including the favorable effects of foreign currency exchange rate fluctuations, increased $25.3 million, or 43.0%, over the comparable period in 2002. The majority of our international revenue is generated in the acute care setting. International rental revenue increased $17.0 million, or 43.5%, from the prior-

Table of Contents

year period and sales revenue was up $8.3 million, or 42.2%, compared to the prior year. Favorable foreign currency exchange movements accounted for $11.6 million of the total international revenue increase when compared to the prior year period. On a constant exchange basis, total international revenue increased $13.8 million, or 21.8%, from the prior-year period, rental revenue increased $9.2 million, or 21.9%, and sales revenue increased $4.6 million, or 21.7%. The rental revenue increase reflects a 58.8% increase in V.A.C. systems out on rent along with a 5.2% increase in therapeutic surface rental units in use, primarily in overlays. We also experienced improved rental pricing for our V.A.C. systems and our therapeutic surfaces for the six months ended June 30, 2003 as compared to the same period in the prior year. The international sales increase was due to increased demand for V.A.C. systems and related disposables.

Rental Expenses:  Rental, or "field," expenses of $166.5 million for the six-month period increased $38.0 million, or 29.6%, from $128.4 million in the prior-year period. The field expense increase was due primarily to increased labor, incentive compensation, parts, and product licensing expenses directly associated with the growth in V.A.C. therapy revenue. Of the $38.0 million variance in rental expenses for the six months ended June 30, 2003, approximately $7.9 million resulted from favorable foreign currency exchange movements. Field expenses for the first half of 2003 represented 61.6% of total rental revenue compared to 61.4% in the first half of 2002.

Cost of Goods Sold:  Cost of goods sold of $28.4 million in the first six months of 2003 increased $7.0 million, or 32.7%, from $21.4 million in the prior year due to increased sales of V.A.C. disposables and higher excess and obsolescence inventory reserve provisions related to therapeutic surface products with low demand. Sales margins increased to 64.0% in the first six months of 2003 as compared to 61.3% in the prior-year period due to the shift away from all-inclusive pricing arrangements discussed above and cost reductions resulting from favorable pricing in our global supply contract for V.A.C. disposables entered into in December 2002.

Gross Profit:  Gross profit in the first six months of 2003 increased approximately $39.8 million, or 34.7%, to $154.2 million from $114.5 million in the prior year due primarily to the year-to-year increase in revenue resulting from increased demand for V.A.C. systems and related disposables. Gross profit margin in the first six months of 2003 was 44.2%, up slightly from 43.3% in the prior year due primarily to the increase in revenue discussed above.

Selling, General and Administrative Expenses:  Selling, general and administrative expenses increased $21.6 million, or 33.9%, to $85.4 million in the first six months of 2003 from $63.8 million in the prior-year period. This increase was due primarily to an increase in variable costs associated with increased revenue from V.A.C. systems along with increases in insurance costs of $2.0 million and professional fees of $2.6 million. As a percentage of total revenue, selling, general and administrative expenses increased slightly to 24.5% in the first six months of 2003 as compared to 24.1% in the first six months of 2002.

Operating Earnings:  Operating earnings for the first six months of 2003 increased $18.1 million, or 35.8%, to $68.8 million compared to $50.7 million in the prior-year period. The increase in operating earnings was directly attributable to the increase in revenue, partially offset by higher operating costs and expenses. Operating margins for the first six months of 2003, were 19.7%, up from 19.2% in the prior year period, due to the increase in revenue without a corresponding increase in costs and expenses.

Table of Contents

Non-GAAP Measure:  We find earnings before interest expense, taxes and depreciation and amortization, or EBITDA, to be useful for measuring our ability to service our debt and our ability to generate cash for other purposes. EBITDA is a non-GAAP measure and should not be considered in isolation from, and is not intended to represent an alternative measure of, operating or net earnings or cash flow or any other measure of performance determined in accordance with GAAP. In addition, our definition of EBITDA is not necessarily comparable to similarly titled measures reported by other companies. The following table presents a reconciliation of EBITDA to net earnings, which we believe is the most directly comparable financial measure in accordance with GAAP for the six months ended June 30, 2003 and 2002 (dollars in thousands):

Six months ended   

June 30,

2003  

2002  

Net earnings

$  35,945 

$  20,029 

Interest expense

16,228 

20,692 

Depreciation and amortization (1)

20,833 

16,505 

Income taxes

21,567 

12,538 

______ 

______ 

        EBITDA

$ 94,573 

$ 69,764 

_____ 

_____ 

      (1) Excludes amortization of loan issuance costs, which is included in interest expense.

EBITDA for the first six months of 2003 increased $24.8 million, or 35.6%, from the prior-year period due substantially to the change in operating earnings discussed above.

Interest Expense:  Interest expense in the first six months of 2003 was $16.2 million compared to $20.7 million in the prior year. The interest expense decrease was due primarily to the partial paydown on our existing credit facility resulting from the $175 million litigation settlement payment received in January 2003. (See Notes 5 and 9 of Notes to Condensed Consolidated Financial Statements.)

Net Earnings:  Net earnings of $35.9 million for the first six months of 2003 increased $15.9 million, or 79.5%, from the prior-year period due to the increase in operating earnings discussed above. Effective tax rates for the first six months of 2003 and 2002 were 37.5% and 38.5%, respectively.

 

Liquidity and Capital Resources

General

      We require capital principally for capital expenditures, systems infrastructure, debt service and working capital, including the need for workspace for our expanding workforce. Our capital expenditures consist primarily of manufactured rental assets and computer hardware and software. Working capital is required principally to finance accounts receivable and inventory. Our working capital requirements vary from period to period depending on manufacturing volumes, the timing of shipments and the payment cycles of our customers and payers.

Sources of Capital

      During the next twelve months, we expect our principal sources of capital to be cash on hand, (1) cash flows from operating activities and (2) availability under the revolving credit facility. Based upon the current level of operations, we believe that these sources of capital will be adequate to meet our anticipated cash requirements for debt repayments, working capital and capital expenditures.

Table of Contents

      On July 11, 2003, we announced our intent to refinance our existing senior credit facility and our Senior Subordinated Notes Due 2007. This recapitalization would reduce near-term amortization requirements and provide additional liquidity. We cannot give any assurance that we will be successful in raising additional capital. (See Note 11 of Notes to Condensed Consolidated Financial Statements and Part II, Item 5. Other Information-Recent Developments.)

      During the first six months of 2003, our primary source of capital was cash from operations. The following table summarizes the net cash provided and used by operating activities, financing activities and investing activities for the six month periods ended June 30, 2003 and 2002 (dollars in thousands):

 

  Six months ended

 

     June 30,

 

  2003      

  2002    

     

Net cash provided by operating activities

$  198,705 (1) 

$   23,927 

     

Net cash used by investing activities

(37,696)     

(32,369)

     

Net cash provided (used) by financing activities

(114,010) (2)

17,096 

 

______      

______ 

      Total

$    46,999      

$   8,654 

 

_____      

_____ 

      (1) Includes receipt of $130 million, net of taxes paid, related to antitrust lawsuit settlement.

      (2) Includes paydown of $107 million of indebtedness on the senior credit facility utilizing
            funds received related to antitrust lawsuit settlement.

      At June 30, 2003, cash and cash equivalents of $103.0 million were available for general corporate purposes. Availability under the revolving portion of our existing senior credit facility was $39.1 million. We are committed to purchase approximately $16.9 million of inventory associated with new products over the next twelve months as of June 30, 2003. We did not have any other material purchase commitments as of June 30, 2003.

Working Capital

      At June 30, 2003, we had current assets of $308.2 million and current liabilities of $143.0 million resulting in a working capital surplus of $165.2 million, compared to a surplus of $243.9 million at December 31, 2002. The paydown of amounts outstanding under our existing senior credit facility with funds from the payment received pursuant to the Hillenbrand settlement accounted for a majority of this change. Operating cash flows for the first six months of 2003 were $198.7 million as compared to $23.9 million for the prior-year period. This increase in operating cash flows was due primarily to the Hillenbrand settlement, higher earnings for the period of $15.9 million and improved working capital management.

      During the remainder of 2003, we expect demand for V.A.C. systems and related disposables to continue to increase, which could have the effect of increasing accounts receivable due to extended payment cycles for third party payers. We have adopted a number of policies and procedures to reduce these extended payment cycles, which we believe have been effective and will continue to improve our collection turnaround times. For example, our revenue for the first six months of 2003 grew 32.1% over the prior-year period and our receivables have increased only 15.3% for the same period. If we were to have an increase in accounts receivable, we would expect to manage such an increase with available cash on hand and, if necessary, through increased borrowing under our credit arrangements, the refinancing of existing indebtedness or through the incurrence of additional indebtedness through new lending arrangements. We expect that cash on hand, cash flow from o perations and additional borrowings under our credit agreements will be sufficient to meet our working capital needs.

 

Table of Contents

Capital Expenditures

      During the first six months of 2003, we made net capital expenditures of $35.0 million compared to $27.6 million in the prior-year period. The period-to-period increase is primarily due to purchases of materials for V.A.C. systems and other high-demand rental products. As of June 30, 2003, we have commitments to purchase new product inventory of $16.9 million over the next twelve months. Other than commitments for new product inventory we have no material long-term purchase commitments. We expect future demand for V.A.C. systems to increase, which will require increased capital expenditures over time.

Debt Service

      In August of this year, we anticipate entering into a new senior credit facility consisting of a $480 million term loan and a $100 million revolving credit facility. We expect to borrow $480 million under the new term loan facility and to use the proceeds from this new credit facility as part of a recapitalization of KCI which is expected to result in the redemption of all of our 9 5/8% Senior Subordinated Notes Due 2007 and the repayment of outstanding indebtedness under our existing credit facility. (See "Part II, Item 5. Other Information-Recent Developments and the discussion of FASB Interpretation No. 46 in "--New Accounting Pronouncements.")

      As of June 30, 2003, scheduled principal payments under the existing senior credit facility for the remainder of the year were $12.8 million. Required principal payments for the years 2004 and 2005 are $58.2 million and $76.4 million, respectively. Based upon the current level of operations, we anticipate that cash on hand, cash flow from operations and the anticipated $75 million remaining to be paid under the antitrust litigation settlement will be adequate to meet our anticipated cash requirements for debt repayments, working capital and capital expenditures.

Existing Senior Credit Facility

      Our existing senior credit facility consists of five term loans and a revolving credit facility. The following table sets forth the amounts owing under each term loan and the revolving credit facility, the effective interest rates on such outstanding amounts, and amounts available for additional borrowing thereunder, as of June 30, 2003 (dollars in thousands):

     

Amounts

 

Effective

 

Available for

 

Interest

Amounts

Additional

Senior Credit Facility

Rate (1)

Outstanding

Borrowing

       

Revolving credit facility, due 2003

-

$            -  

$   39,083 (2) 

Tranche A term loan due 2003

3.67% 

11,742  

-      

Tranche B term loan due 2004

4.63% 

57,068  

-      

Tranche C term loan due 2005

4.96% 

57,068  

-      

Tranche D term loan due 2006

4.80% 

62,470  

-      

Tranche E term loan due 2005

4.96% 

19,878  

-      

   

_______  

______      

      Total

 

$  208,226  

$   39,083      

______  

_____      

 

      (1) Effective interest rates take into account existing interest rate hedging arrangements
      and fees related to letters of credit and unused commitments.

      (2) This amount reflects a reduction from $50.0 million to the extent of the principal amount of
      the outstanding letters of credit issued on our behalf. As of June 30, 2003 approximately
      $10.9 million in letters of credit had been issued.

      The term loans, other than Tranches D and E, are subject to quarterly amortization payments. The Tranche D term loan amortizes at 1% per year through December 31, 2005 with a final payment of $60.9 million (less any future prepayments made through that date) due March 31, 2006. The

Table of Contents

Tranche E term loan amortizes at 1% per year with a final payment of $19.4 million (less any future prepayments made through that date) due December 31, 2005. We may borrow additional funds under the revolving credit facility at any time up to the borrowing limits thereunder. As of June 30, 2003, we had no revolving loans outstanding. However, we had outstanding five letters of credit in the aggregate amount of $10.9 million. The resulting availability under the revolving credit facility was $39.1 million at the end of the quarter.

      Our indebtedness under the existing senior credit facility is guaranteed by certain of our subsidiaries and is secured by a first priority security interest in (1) all of our tangible and intangible assets and those of our domestic subsidiaries (subject to certain customary exceptions), including, without limitation, intellectual property and real estate owned by us and our subsidiaries, and (2) substantially all shares of capital stock and intercompany debt of each of our present and future subsidiaries (limited in the case of certain foreign subsidiaries to 65% of the voting stock of such entity).

      Our existing senior credit agreement requires us to meet certain financial tests, including minimum levels of EBITDA (as defined in the credit agreement), minimum interest coverage, maximum leverage ratio and capital expenditures. The senior credit agreement also contains covenants which, among other things, limit our ability to:

          - incur additional indebtedness;
          - make investments;
          - announce or pay dividends;
          - make loans and advances;
          - make capital expenditures;
          - enter into transactions with affiliates;
          - dispose of our assets;
          - enter into acquisitions, mergers or consolidation transactions;
          - make prepayments on other indebtedness;
          - create or permit to be created any liens on any of our properties; or
          - undertake certain other matters customarily restricted in such agreements.

      As of June 30, 2003, we were in compliance with all applicable covenants.

      Our existing senior credit agreement also contains customary events of default, including payment defaults, any breach of representations and warranties, covenant defaults, cross-defaults to certain other indebtedness, certain events of bankruptcy and insolvency, failures under ERISA plans, judgment defaults, any change in our company's control and failure of any guaranty, security document, security interest or subordination provision under the senior credit agreement. In addition, the senior credit agreement provides for mandatory repayments, subject to certain exceptions, of the term loans and the revolving credit facility based on certain net asset sales outside the ordinary course of our business and our subsidiaries' business, the net proceeds of certain debt and equity issuances and excess cash flows. We expect that the new senior credit facility, which we expect to enter into in August 2003, will have covenants and restrictions similar to those under the existing senior credit facility. (See "Part II, Item 5. Other Information-Recent Developments.")

Senior Subordinated Notes

      In 1997, we issued $200.0 million of 9 5/8% senior subordinated notes due 2007. The notes are unsecured obligations, ranking subordinate in right of payment to all of our senior debt and will mature on November 1, 2007. As of June 30, 2003, the entire $200.0 million of our notes were issued and outstanding. As part of the planned recapitalization, we expect to redeem all of the outstanding notes. (See "Part II, Item 5. Other Information-Recent Developments.")

      The notes are not entitled to the benefit of any mandatory sinking fund. They are redeemable, at our option, in whole at any time or in part from time to time, at the following redemption prices (expressed as percentages of the principal amount thereof) if redeemed during the twelve-month

Table of Contents

period commencing on November 1 of the year set forth below, plus, in each case, accrued and unpaid interest thereon, if any, to the date of redemption.

Year

Percentage

2002

104.813%

2003

103.208%

2004

101.604%

2005 and thereafter

100.000%

      Under the existing senior subordinated indenture agreement, we may at any time, or from time to time, acquire a portion of the notes through open-market purchases. In order to affect the foregoing redemption with the proceeds of any equity offering, we would make the redemption not more than 120 days after the consummation of any such equity offering.

      Under the indenture governing the outstanding notes, we are subject to customary covenants, which, among other things, restrict our ability to:

          - incur additional indebtedness;
          - incur liens;
          - announce or pay dividends or make certain other restricted payments;
          - consummate certain asset sales;
          - enter into certain transactions with affiliates;
          - incur indebtedness that is subordinate in right of payment to any senior debt and senior in
              right of payment to the notes;
          - merge or consolidate with any other person; or
          - sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the KCI
              assets.

      The indenture governing our notes contains customary events of default, including nonpayment of principal or interest, violations of covenants, inaccuracy of representations or warranties in any material respect, cross default and cross acceleration to certain other indebtedness, bankruptcy, material judgments and liabilities, change of control and any material adverse change in our financial condition.

Interest Rate Protection

      We have variable interest rate debt and other financial instruments, which are subject to interest rate risk and could have a negative impact on our business if not managed properly. We have a risk management policy, which is designed to reduce the potential negative earnings effect arising from the impact of fluctuating interest rates. We use interest rate swap agreements to minimize the impact of fluctuating interest rates. These contracts are initiated within the guidance of corporate risk management policies and are reviewed and approved by our top financial management. We do not use financial instruments for speculative or trading purposes.

      As of December 31, 2002, two $100 million interest rate swap agreements were in effect to take advantage of low interest rates. On January 31, 2003, we sold $20 million of our $100 million, 1.7450% interest rate swap effective March 31, 2003 which resulted in an expense of approximately $74,000 which was recorded in the first quarter of 2003. As of June 30, 2003, the current interest rate swap agreements effectively fix the base-borrowing rate on 86% of our variable rate debt. The fair value of these swaps at inception was zero. Due to subsequent movements in interest rates, as of June 30, 2003, the fair values of the $80 million and $100 million swap agreements were negative and were adjusted to reflect a liability of approximately $300,000 and $1.6 million, respectively.

 

Table of Contents

Long Term Commitments

      We are committed to making cash payments in the future on long term debt, capital leases, operating leases and purchase commitments. We have not guaranteed the debt of any other party. The table below sets forth our contractual obligations and future liquidity demands as of June 30, 2003 (dollars in thousands):

 

                         Payments Due                         

 

   Total 

< 1 year

1-2 years

3-4 years

5+ years

           

Long term debt amortization

$ 408,676 

$  13,939 

$ 194,737 

$ 200,000 

$            - 

           

Capital lease payments

170 

151 

19 

           

Operating lease payments (1)

75,901 

16,805 

25,323 

17,423 

16,350 

           

Purchase commitments

16,931 

16,931 

 

_______ 

______ 

_______ 

_______ 

______ 

               Totals

$ 501,678 

$  47,826 

$ 220,079 

$ 217,423 

$    16,350 

 

______ 

_____ 

______ 

______ 

_____ 

      (1) There have been no material changes outside the ordinary course of business in long term
      commitments for operating lease payments from the information provided in KCI's Annual
      Report on Form 10-K for the year ended December 31, 2002.

 

Critical Accounting Policies

      The SEC defines critical accounting policies as those that are, in management's opinion, very important to the portrayal of our financial condition and results of operations and require our management's most difficult, subjective or complex judgments. We are not aware of any reasonably possible events or circumstances that would result in different amounts being reported that would have a material effect on our results of operations or financial position. However, in preparing our financial statements in accordance with generally accepted accounting principles in the United States, we must often make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures at the date of the financial statements and during the reporting period. Some of those judgments can be subjective and complex. Consequently, actual results could differ from our estimates. The accounting policies that are mos t subject to important estimates or assumptions include those described below. (See Note 1 of Notes to Condensed Consolidated Financial Statements.)

Revenue Recognition

      We recognize revenue in accordance with Staff Accounting Bulletin No. 101 when each of the following four criteria are met:

     1. A contract or sales arrangement exists.
     2. Products have been shipped and title has transferred or services have been rendered.
     3. The price of the products or services is fixed or determinable.
     4. Collectibility is reasonably assured.

      We recognize rental revenue based on the number of days a product is in use by the patient/facility and the contracted rental rate. Reductions to rental revenue are recorded to provide for payment adjustments including (1) capitation agreements, (2) evaluation/free trial days, (3) credit memos, (4) rebates, (5) pricing adjustments (6) utilization adjustments, (7) cancellations and (8) payer adjustments. In addition, we establish reserves against revenue to allow for uncollectible items relating to (1) unbilled receivables over 60 days old and (2) patient co-payments, based on historical collection experience.

Table of Contents

Accounts Receivable-Allowance for Doubtful Accounts

      We utilize a combination of factors in evaluating the collectibility of account receivables. For unbilled receivables, we establish reserves against revenue to allow for denied or uncollectible items beginning at 60 days after the end of service or usage. Items that remain unbilled for more than 90 days or beyond an established billing window are reversed out of revenue and receivables. For billed receivables, we generally establish reserves for bad debt based on the length of time that the receivables are past due. The reserve rates vary by payer group and are based upon our historical experience on a weighted average basis. The reserves range in value from 0% for current amounts to 100% for amounts over 180 days for certain payer groups. In addition, we have recorded specific reserves for bad debt when we become aware of a customer's inability to satisfy its debt obligations, such as in the event of a bankruptcy filing. If circumstances change su ch as, higher than expected claims denials, payment defaults or an unexpected material adverse change in a major customer's or payer's ability to meet its obligations, our estimates of the realizability of amounts due from trade receivables could be reduced by a material amount.

Goodwill and Other Intangible Assets

      Goodwill represents the excess purchase price over the fair value of net assets acquired. Goodwill represented 7.5% and 12.5% of total assets at December 31, 2002 and December 31, 2001, respectively. Effective January 1, 2002, we applied the provisions of Statement of Financial Accounting Standards No. 142, ("SFAS 142"), Goodwill and Other Intangible Assets in our accounting for goodwill. SFAS 142 requires that goodwill and other intangible assets that have indefinite lives not be amortized but instead by tested at least annually for impairment, or more frequently when events or changes in circumstances indicate that the asset might be impaired. For indefinite lived intangible assets, impairment is tested by comparing the carrying value of the asset to the fair value of the reporting unit to which they are assigned.

      Goodwill was tested for impairment during the first and fourth quarters of 2002 and will be tested for impairment at least annually, in the fourth quarter, using a two-step process. The first step is a comparison of an estimation of the fair value of a reporting unit with the reporting unit's carrying value. We have determined that our reporting units are our two operating segments - USA and International. If the fair value of a reporting unit exceeds its carrying amount, the goodwill of the reporting unit is not considered impaired, and as a result, the second step of the impairment test is not required. If required, the second step compares the fair value of reporting unit goodwill with the carrying amount of that goodwill. If we determine that reporting unit goodwill is impaired, the fair value of reporting unit goodwill would be measured by comparing the discounted expecte d future cash flows of the reporting unit with the carrying value of reporting unit goodwill. Any excess in the carrying value of reporting unit goodwill to the estimated fair value would be recognized as an expense at the time of the measurement. We recorded no impairments to our reporting units as a result of the implementation of SFAS 142 during 2002.

      The goodwill of a reporting unit will be tested annually or if an event occurs or circumstances change that would likely reduce the fair value of a reporting unit below its carrying amount. Examples of such events or circumstances include, but are not limited to: a significant adverse change in legal or business climate, an adverse regulatory action or unanticipated competition.

Inventory

      Inventories are stated at the lower of cost (first-in, first-out) or market (net realizable value). Costs include material, labor and manufacturing overhead costs. Inventory expected to be converted into equipment for short-term rental is reclassified to property, plant and equipment. We review our inventory balances monthly for excess sale products or obsolete inventory levels. Except where firm orders are on-hand, inventory quantities of sale products in excess of the last twelve months demand are considered excess and are reserved at 50% of cost. For rental products, we review both product usage and product life cycle to classify inventory as active, discontinued or obsolete. Obsolescence reserve balances are established on an increasing basis from 0% for active, high-demand products to

Table of Contents

100% for obsolete products. The reserve is reviewed, and if necessary, adjustments made on a monthly basis. We rely on historical information to support our reserve and utilize management's business judgment for "high risk" items, such as products that have a fixed shelf life. Once the inventory is written down, we do not adjust the reserve balance until the inventory is sold.

Long Lived Assets

      Property, plant and equipment are stated at cost. Betterments, which extend the useful life of the equipment, are capitalized. Depreciation on property, plant and equipment is calculated on the straight-line method over the estimated useful lives (thirty to forty years for buildings and between three and five years for most of our other property and equipment) of the assets. We have not had an event that would indicate impairment of our tangible long-lived assets. If an event were to occur, we would review property, plant and equipment for impairment using an undiscounted cash flow analysis and if an impairment had occurred on an undiscounted basis, we would compute the fair market value of the applicable assets on a discounted cash-flow basis and adjust the carrying value accordingly.

Income Taxes

      We operate in multiple tax jurisdictions with different tax rates and must determine the allocation of income to each of our jurisdictions based on estimates and assumptions. In the normal course of our business, we will undergo scheduled reviews by taxing authorities regarding the amount of taxes due. These reviews include questions regarding the timing and amount of deductions and the allocation of income among various tax jurisdictions. Tax reviews often require an extended period of time to resolve and may result in income tax adjustments if changes to the allocation are required between jurisdictions with different tax rates.

Legal Proceedings and Other Loss Contingencies

      We are subject to various legal proceedings, many involving routine litigation incidental to our business. The outcome of any legal proceeding is not within our complete control, is often difficult to predict and is resolved over very long periods of time. Estimating probable losses associated with any legal proceedings or other loss contingencies is very complex and requires the analysis of many factors including assumptions about potential actions by third parties. Loss contingencies are recorded as liabilities in the consolidated financial statements when it is both (1) probable or known that a liability has been incurred and (2) the amount of the loss is reasonably estimable, in accordance with Financial Accounting Standards Statement No. 5, "Accounting for Contingencies." If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. I f a loss contingency is not probable or not reasonably estimable, a liability is not recorded in the consolidated financial statements.

 

New Accounting Pronouncements

      In June 2001, the Financial Accounting Standards Board ("FASB") issued SFAS 143, "Accounting for Asset Retirement Obligations," effective for fiscal years beginning after June 15, 2002. This standard addresses financial accounting and reporting obligations associated with the retirement of tangible long-lived assets and the associated asset retirement costs. The standard requires us to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred and to adjust its present value in each subsequent period. In addition, we must capitalize an amount equal to the adjustment by increasing the carrying amount of the related long-lived asset, which is depreciated over the remaining useful life of the related asset. We adopted SFAS 143 during the first quarter of 2003 and it did not have a significant effect on our financial position or results of operations.

Table of Contents

      In January 2003, the FASB issued Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities," effective for fiscal years or interim periods beginning after June 15, 2003. FIN 46 addresses accounting for, and disclosure of, variable interest entities. FIN 46 requires the disclosure of the nature, purpose and exposure of any loss related to our involvement with variable interest entities. We adopted the provisions of FIN 46 for post January 31, 2003 variable interest entities during the first quarter of 2003 and it did not have a significant effect on our financial position or results of operations. We continue to evaluate the potential effects of the consolidation provisions of FIN 46 that will be adopted during the quarter ended September 30, 2003.

      Specifically, we are evaluating the beneficial ownership of two Grantor Trusts which we acquired in December 1996 and December 1994. The assets held by each Trust consist of a McDonnell Douglas DC-10 aircraft and three engines. In connection with the acquisitions, KCI paid cash of $7.2 million and $7.6 million, respectively. The Trusts held debt of $48.4 million and $51.8 million, respectively, which is non-recourse to KCI. The DC-10 aircraft are leased to the Federal Express Corporation through June 2012 and January 2012, respectively. Federal Express pays monthly rent to a third party who, in turn, pays the entire amount to the holders of the non-recourse indebtedness, which is secured by the aircraft. The holder's recourse in event of a default is limited to the Trusts assets.

      In April 2003, the FASB issued Statement of Financial Accounting Standards No. 149 (SFAS 149), "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." This statement amends SFAS 133 to provide clarification on the financial accounting and reporting of derivative instruments and hedging activities and requires contracts with similar characteristics to be accounted for on a comparable basis. The Company does not expect the adoption of SFAS 149, which will be effective for contracts entered into or modified after June 30, 2003, to have a material effect on its financial condition or results of operations.

      On May 15, 2003, the FASB issued SFAS 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." The statement established standards for classifying and measuring as liabilities certain financial instruments that embody obligations of the issuer and have characteristics of both liabilities and equity. SFAS 150 must be applied immediately to instruments entered into or modified after May 31, 2003. (See Notes 1 and 11 of Notes to Condensed Consolidated Financial Statements.)

 

RISK FACTORS

Risk Related to our Business

We face significant competition, and if we are unable to compete effectively, we may lose market share or be required to reduce prices.

      The competition for our V.A.C. systems in wound healing and tissue repair is composed of wound-healing modalities which do not operate in a manner similar to V.A.C. systems, including traditional wound care dressings, advanced wound care dressings, skin substitutes, products containing growth factors and medical devices used for wound care. Our primary competitor in the therapeutic surface business is Hill-Rom Company, whose financial and other resources substantially exceed those available to us. In Europe, we also face competition from Huntleigh Healthcare and Pegasus Limited.

      Competitive conditions could intensify in our markets. Competitors may:
       -  develop or commercialize new technologies which are more effective than our products;
       -  introduce new competing products with greater safety or efficacy or at lower prices;
       -  secure exclusive arrangements with health care providers and GPOs;
       -  devote greater resources to marketing and promotional campaigns;
       -  secure regulatory clearances or approvals that surpass those of our products; or
       -  obtain services, products and materials from suppliers on more favorable terms.

 

Table of Contents

If a product similar to the V.A.C. system is introduced into the market by a competitor and we are unable to use our patent rights to enjoin the sale of such a product, we could experience decreased demand or we could be required to reduce prices, either of which could materially harm our results of operations.

      Any of the foregoing could impair our ability to compete effectively, which could have a material adverse effect on our business, financial condition or results of operations.

We may incur substantial costs in protecting our intellectual property, and if we are unable to effectively protect it, our competitive position would be harmed.

      We place considerable importance on obtaining and maintaining patent protection for our products. We have numerous patents on our existing products and processes and we file applications as appropriate for patents covering new technologies as they are developed. However, we cannot be sure that the patents we own, or in which we have rights, will be sufficiently broad to protect our technology position against competitors. Issued patents owned by, or licensed to, us may be challenged, invalidated or circumvented, or the rights granted under the patent may not provide us with competitive advantages. We would incur substantial costs and diversion of management resources if existing disputes are not resolved amicably, or if we have to assert our patent rights against others. Any unfavorable outcome in intellectual property disputes or litigation could have a material adverse effect on our business. In addition, we may not be able to detect infringeme nt by third parties, and could lose our competitive position if we fail to do so quickly.

      Further, our efforts to protect our intellectual property rights may be less effective in some countries where intellectual property rights are not as well protected as in the United States. Many U.S. companies have encountered substantial problems in protecting their proprietary rights against infringement in foreign countries. If we fail to adequately protect our intellectual property rights in these countries, it could be easier for our competitors to sell competing products.

      We also rely on a combination of copyright, trade secret and other laws, and contractual restrictions on disclosure, copying and transferring title, including confidentiality agreements with vendors, strategic partners, co-developers, employees, consultants and other third parties, to protect our proprietary rights. We cannot give assurance that such protections will prove adequate and that contractual agreements will not be breached, that we will have adequate remedies for any such breaches, or that our trade secrets will not otherwise become known to or independently developed by others. We have trademarks, both registered and unregistered, that are maintained and enforced to provide customer recognition for our products in the marketplace. We cannot provide assurance that our trademarks will not be used by unauthorized third parties, or that we wall be able to stop such unauthorized use if it occurs. We also have agreements with third parties that pro vide for licensing of patented or proprietary technologies. These agreements include royalty-bearing licenses. If we were to lose the rights to license these technologies or our costs to license these technologies were to materially increase, our business would suffer.

Third parties may claim we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling our products.

      The markets in which we compete are characterized by a substantial amount of litigation over patent and other intellectual property rights. Our competitors, like companies in other high technology businesses, continually review other companies' products for possible conflicts with their own intellectual property rights. Determining whether a product infringes a third party's intellectual property rights involves complex legal and factual issues, and the outcome of this type of litigation is often uncertain. Third parties may claim that we are infringing their intellectual property rights, and we may be found to infringe those intellectual property rights. While we do not believe that any of our products infringe the valid intellectual property rights of third parties, we may not be aware of intellectual property rights of others that relate to our products, services or technologies. From time to time, we have received notices from third parties a lleging infringement of patent or other intellectual property rights relating to their products, and we

 

Table of Contents

have ongoing lawsuits in which third parties have accused us of infringing and misappropriating their intellectual property. Any contest regarding patents or other intellectual property could be costly and time-consuming, and could divert our management and key personnel from our business operations. We cannot provide assurance that we will prevail in any such contest. If we are unsuccessful, we may be subject to significant damages or injunctions against development and sale of our products, or may be required to enter into costly royalty or license agreements. We cannot be certain that any licenses required would be made available or that the terms of any proposed license would be acceptable.

If we are unable to develop new generations of products and enhancements to existing products, we may be unable to attract or retain customers.

      Our success is dependent upon the successful development, introduction and commercialization of new generations of products and enhancements to existing products. Our products are technologically complex and must keep pace with rapid and significant technological change, must comply with rapidly evolving industry standards and must compete effectively with new product introductions of our competitors. Accordingly, many of our products require significant planning, design, development and testing at the technological, product and manufacturing process levels. These activities require significant capital commitments and investments on our part, which we may be unable to recover.

      Our ability to successfully develop and introduce new products and product enhancements, and the associated costs, are also affected by our ability to:
       -  properly identify customer needs;
       -  solve the technical problems associated with product innovations designed to meet our customers
             needs;
       -  prove feasibility of new products;
       -  limit the time required from proof of feasibility to commercialization:
       -  predict and manage the timing, cost and results of regulatory approvals;
       -  accurately predict and control costs associated with inventory overruns caused by phase-in of
             new products and phase-out of old products;
       -  price our products competitively:
       -  manufacture and deliver our products in sufficient volumes on time;
       -  accurately predict and control costs associated with manufacturing, installation, warranty and
             maintenance of the products;
       -  manage customer demands for retrofits of both new and old products; and
       -  anticipate and compete successfully with competitors' efforts and intellectual property.

      As a result, we cannot be sure that we will be able to successfully develop, manufacture and commercialize new products or product enhancements. Without the successful introduction of new products and product enhancements, we may be unable to attract and retain customers and our revenue and operating results will suffer. In addition, even if customers accept new products or product enhancements, the revenue from such products may not be sufficient to offset the significant costs associated with making such products available to customers.

We depend on revenue from sales and rentals of V.A.C. products.

      For the twelve-month period ended June 30, 2003, we derived 59.0% of our revenue from V.A.C. sales and rentals. We expect that revenue from V.A.C. products will continue to be the predominant source of our revenue for the foreseeable future. If revenue from V.A.C. sales and rentals does not grow as we anticipate, our results of operations and financial condition could suffer.

 

Table of Contents

If we are unable to provide the significant education and training required for the health care market to accept our products, our business will suffer.

      In order to achieve market acceptance for our products, we are often required to educate health care professionals about the use of a new medical device, overcome objections to some of the effects of the device or its related treatment regimen and convince health care payers that the benefits of the device and its related treatment regimen outweigh its costs. For example, the complexity and dynamic nature of our products require education of health care professionals regarding the benefits and the required departures from customary practices. We have expended and will continue to expend significant resources on marketing and educational efforts to create general awareness of our products and to encourage acceptance and adoption of our products. The timing of our competitors' introduction of products and the market acceptance of their products may also make this educational process more difficult. We cannot be sure that any products we develop wil l gain any significant market acceptance and market share among physicians, patients and health care payers even if required regulatory approvals are obtained.

Health care reform could negatively impact demand for our products.

      There are widespread legislative efforts to control health care costs in the United States and abroad, which likely will continue in the future. In the past, these have included freezes in annual payment updates, cuts in payment reimbursement amounts, and efforts to competitively bid durable medical equipment. We cannot assess the likelihood of similar legislative efforts in the future or the impact the enactment of any resulting legislation could have on our business. However, such resulting legislation could have a material adverse effect on our results of operations and financial condition.

Changes to third party reimbursement policies could negatively impact the reimbursement we receive for our products.

      Our products are rented and sold to hospitals and skilled nursing facilities that receive reimbursement for the products and services they provide from various public and private third patty payers, including Medicare, Medicaid and private insurance programs. We also act as a DME supplier and, as such, we furnish our products directly to customers and bill third party payers such as Medicare, Medicaid and private insurance. As a result, the demand for our products in any specific care setting is dependent, in part, on the reimbursement policies (including coverage and payment policies) of the various payers in that setting. Some state and private payers make adjustments to their reimbursement policies to reflect federal changes as well as to make their own changes. If coverage and payment policies for our products are revised or otherwise withdrawn under existing Medicare or Medicaid policies, demand for our products could be negatively impacted, which could have a material adverse affect on our financial condition and results of operations. In addition, in the event any public or private third party payers challenge our billing, documentation or other practices as inconsistent with their reimbursement policies, we could experience significant delays, reductions or denials in obtaining reimbursements. In light of increased controls on health care spending, especially on Medicare and Medicaid spending, there can be no assurance on the outcome of future coverage or payment decisions for any of our products by governmental or private payers.

      The Medicare Part B coverage policy covering V.A.C. systems is complex and requires extensive documentation. In addition, the reimbursement process for the non-governmental payer segment requires extensive contract development and administration with several hundred payers, with widely varying requirements for documentation and administrative procedures, which can result in extended payment cycles. This has made billing home care payers more complex and time consuming than billing other payers. In 2003, the Centers for Medicare and Medicaid Services issued new regulations on inherent reasonableness of such charges and while these regulations do not impact us currently, there can be no assurance of the outcome of future coverage or payment decisions with respect to V.A.C. systems or any of our other products by governmental or private payers. If providers, suppliers and

 

Table of Contents

other users of our products and services are unable to obtain sufficient reimbursement for the provision of our products, a material adverse impact on our business, financial condition or results of operations could result.

Our results of operations are dependent on our ability to timely collect reimbursement payments.

      Our financial condition and results of operations have been and will continue to be affected by our ability to collect reimbursement payments from governmental and private payers for rentals and sales of our devices and services. As of June 30, 2003, we had $159.7 million of receivables outstanding, net of reserves of $32.3 million for doubtful accounts, and for the twelve month period ended June 30, 2003, our receivables were outstanding for an average of 79 days. We expect demand for V.A.C. systems and related disposables to continue to increase in the near future, which could have the effect of increasing accounts receivables due to extended payment cycles for third party payers. We have adopted a number of policies and procedures to improve our collections. However, these policies and procedures may not be effective. If we are unable to timely collect our reimbursement payments, our results would suffer.

We may be subject to claims audits which would harm our business and financial results.

      As a health care supplier, we are subject to extensive government regulation, including laws regulating reimbursement under various government programs. The billing, documentation and other practices of health care suppliers are subject to government scrutiny, including claims audits. To ensure compliance with Medicare regulations, contractors, such as the Durable Medical Equipment Regional Carriers, or DMERCs, which serve as the government's agents for the processing of claims for products sold for home use, periodically conduct audits and request medical records and other documents to support claims submitted by us for payment of services rendered to our customers. Because we are a DME supplier, those audits involving home use involve audits of patient claims records. Such audits can result in delays in obtaining reimbursement and denials of claims for payment submitted by us. For example, we recently received the results of a routine review co nducted by the DMERC for Region A. The review included a sample of 30 claims billed to Medicare for negative pressure wound therapy pumps and supplies between October 1, 2000, and December 31, 2001, from each of our top three billing locations in Region A. In their first review, the DMERC identified certain medical record documentation deficiencies. This resulted in an alleged overpayment of approximately $620,000. We have submitted additional documentation for each of the denied claims in rebuttal of these findings. If we are unsuccessful in reversing the denial, we would be obligated to reimburse the federal government for such payments (plus interest). We would then have opportunities to appeal the denial. As with this DMERC Region A claims audit, other DMERCs can periodically audit our patient claims records and, if alleged overpayments are identified, could demand significant refunds or recoupments of amounts paid by the government for claims which are determined by the DMERCs to be inadequately support ed by the required documentation or for other reasons. Such actions could have a material adverse effect on our business and financial performance.

      In addition, the government could demand significant refunds or recoupments of amounts paid by the government for claims which are determined by the government to be inadequately supported by the required documentation. Such actions could have a material adverse effect on our business and financial performance.

We depend upon a limited group of suppliers and, in some cases, sole-source suppliers.

      We obtain some of the components included in our products from a limited group of suppliers, and in one case, a sole-source supplier. We have entered into a sole-source agreement with Avail Medical Products, Inc., or Avail, for V.A.C. disposables, effective October 2002 for our U.S.-related orders and mid-2003 for our international-related orders. This supply agreement has a three-year term with an automatic extension for an additional twelve months if neither party gives notice of termination. If we lose any supplier (including any sole-source supplier), we would be required to obtain one or more

 

Table of Contents

replacement suppliers and may be required to conduct a significant level of product development to incorporate new parts into our products. We believe that we may be able to obtain alternative sources for such components when necessary, although the need to change suppliers or to alternate between suppliers might cause material delays in delivery or significantly increase costs. Disruptions or loss of any of our limited or sole-source manufacturing for disposables, components or subassemblies, could adversely affect our business and financial results and could result in damage to customer relationships.

A high percentage of our sales are international, and economic, political and other risks associated with international sales and operations could adversely affect our sales or make them less predictable.

      For the twelve-month period ending June 30, 2003, approximately 24% of our revenue, and approximately 16% of our operating earnings (excluding the Hillenbrand settlement), were derived from our international segment. We intend to continue to expand our presence in international markets. Accordingly, our future results could be harmed by a variety of factors, including:
       -  the difficulties in enforcing agreements and collecting receivables under many foreign countries'
             legal systems;
       -  the longer payment cycles associated with many foreign customers;
       -  the possibility that foreign countries may impose additional withholding taxes or otherwise tax
             our foreign income, impose tariffs or adopt other restrictions on foreign trade;
       -  fluctuations in exchange rates, which may affect product demand and adversely affect the
             profitability, in U.S. dollars, of products and services provided by us in foreign markets where
             payment for our products and services is made in the local currency;
       -  our ability to obtain U.S. export licenses and other required export or import licenses or approvals;
       -  changes in the political, regulatory, safety or economic conditions in a country or region; and
       -  the protection of intellectual property in foreign countries may be more difficult to enforce.

We may not be able to maintain or expand our business if we are not able to retain, hire and integrate sufficient qualified personnel.

      Our future success depends to a significant extent on the continued service of members of our key executive, technical, sales, marketing and engineering staff. Our business has been growing rapidly and therefore depends on our ability to attract, expand, integrate, train and retain our management team, qualified engineering personnel and technical personnel. The loss of services of key employees could adversely affect our business. Competition for such personnel can be intense. We compete for key personnel with other medical equipment and technology companies, as well as universities and research institutions. Because the competition for qualified personnel is intense, costs related to compensation could increase if supply decreases or demand increases. If we are unable to hire, train or retain qualified personnel, we will not be able to maintain and expand our business.

If we are unable to manage rapid changes, our business may be harmed.

      We are currently experiencing significant growth in revenue, employees and number of product offerings. This growth has placed a significant strain on our management and our financial, operational, marketing and sales systems. Any failure by us to properly manage our growth could impair our ability to attract and service customers and could cause us to incur higher operating costs and experience delays in the execution of our business plan. We have also experienced reductions in revenue in the past that required us to rapidly reduce costs. If we fail to reduce staffing levels when necessary, our costs would be excessive and our business and operating results could be adversely affected.

 

Table of Contents

We face significant costs in order to comply with laws and regulations governing the health care industry, and failure to comply with applicable regulations could limit our ability to promote and distribute our products and could subject us to civil or criminal penalties.

      Substantially all of our products are subject to regulation by the U.S. Food and Drug Administration, or FDA, and its foreign counterparts. Complying with FDA requirements and other applicable regulations imposes significant costs and expenses on our operations. If we fail to comply with applicable regulations, we could be subject to enforcement sanctions, our promotional practices may be restricted, and our marketed products could be subject to recall or otherwise impacted, which could have a material adverse effect on our business. In addition, new regulations such as the U.S. Health Insurance Portability and Accountability Act of 1996, or HIPAA, that regulate the way we do business will result in increased compliance costs. There can be no assurance that current or future regulatory initiatives, either domestically or internationally, will not have a material adverse effect on our business, financial condition or results of operations.

      In October, 2002, an PDA inspector noted several noncompliance conditions after an inspection of our principal manufacturing facility. Although we believe we have adequately responded to the inspector's observations, there can be no assurance that the PDA will not initiate an enforcement action based upon the observations.

      We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, privacy and security of individually identifiable health information, standardization of electronic data transactions and code sets, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances. Changes in existing requirements or adoption of new requirements could have a material adverse effect on our business, financial condition and results of operations. There can be no assurance that we will not incur significant costs to comply with laws and regulations in the future or that laws and regulations will not have a material adverse effect upon our business, financial condition or results of operations.

      We are also subject to various federal and state laws pertaining to health care fraud and abuse including prohibitions on the submission of false claims and the payment or acceptance of kickbacks or other remuneration in return for the purchase or lease of our products. The United States Department of Justice and the Office of the Inspector General of the United States Department of Health and Human Services has launched an enforcement initiative which specifically targets the long term care, home health and DME industries. Sanctions for violating these laws include criminal penalties and civil sanctions, including fines and penalties, and possible exclusion from the Medicare, Medicaid and other federal health care programs. Although we believe our business arrangements comply with federal and state fraud and abuse laws, there can be no assurance that our practices will not be challenged under these laws in the future or that such a challenge would not h ave a material adverse effect on our business, financial condition or results of operations.

Product liability claims could expose us to adverse judgments or could affect the demand for our products.

      The manufacturing and marketing of medical products necessarily entails an inherent risk of product liability claims. Although we have not experienced any material losses due to product liability claims and currently maintain umbrella liability insurance coverage, there can be no assurance that the amount or scope of the coverage maintained by us will be adequate to protect us in the event a significant product liability claim is successfully asserted against us.

Table of Contents

ITEM 3.     QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

      There have been no material changes from the information provided in KCI's Annual Report on Form 10-K for the year ended December 31, 2002 in regard to market risk.

 

ITEM 4.     CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

      As of the end of the fiscal quarter covered by this report, an evaluation was performed under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of the evaluation date. During the fiscal quarter covered by this report, there have been no material changes in our disclosure controls and procedures or in other factors, which could significantly affect such controls and procedures.

 

Changes in Internal Control

      During the fiscal quarter covered by this report, there have been no significant changes in KCI's internal control (as such term is defined in rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended) or in other factors which could significantly affect internal control.

 

Table of Contents

PART II - OTHER INFORMATION

ITEM 1.     LEGAL PROCEEDINGS

      There have been no material changes from the information provided in KCI's Annual Report on Form 10-K for the year ended December 31, 2002 in regard to legal proceedings.

ITEM 4.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

      As permitted by the Texas Business Corporation Act and Article VII, Clause II of KCI's Amended and Restated Articles of Incorporation, the shareholders of KCI took action by written consent in lieu of a special meeting to elect new members to the board of directors and to re-elect existing members of the board until their respective successors are elected and qualified. The names of the directors so elected and re-elected are as follows:

1. Ronald W. Dollens

7. Dennert O. Ware

2. James T. Farrell

8. C. Thomas Smith

3. Robert Jaunich II

9. John P. Byrnes

4. James R. Leininger, M.D.

10. Harry R. Jacobson, M.D.

5. N. Colin Lind

11. David J. Simpson

6. Donald E. Steen

 

In addition, the shareholders further took action by written consent in lieu of a special meeting to amend the Bylaws of KCI to increase the maximum number of directors permitted to serve on the board of directors from ten to twelve. These actions took place through two written consents which became effective on May 28, 2003 and July 1, 2003, respectively. Mr. Simpson was elected to office with 66,730,525 votes cast for his election and no votes withheld. Each other director was elected to office with 66,792,935 votes cast for their election and no votes withheld. The amendment of the Bylaws was approved with 66,730,525 votes cast in favor of amending the Bylaws and no votes cast against.

 

ITEM 5.     OTHER INFORMATION

Recent Developments

      On July 11, 2003, we announced that we entered into a commitment letter with Morgan Stanley Senior Funding, Inc. and Credit Suisse First Boston for a new senior secured credit facility. The new facility would be composed of a $480 million term loan and a $100 million revolving credit facility. We expect to borrow $480 million under the new term loan facility and to use the proceeds from the new credit facility as part of a recapitalization of KCI, which is expected to result in the redemption of all of our outstanding 9 5/8% Senior Subordinated Notes Due 2007 and the repayment of outstanding indebtedness under our existing credit facility. The closing of the new credit facility is expected to occur in mid-August 2003, but is subject to a number of important conditions. There can be no assurance that these conditions will be satisfied or that the terms described above will not change.

 

 

Table of Contents

ITEM 6.     EXHIBITS AND REPORTS ON FORM 8-K

             (a)   Exhibits

        A list of all exhibits filed or included as part of this quarterly report on form 10-Q is as follows:

 Exhibits

Description

   

3.1    

Restatement of Articles of Incorporation (filed as Exhibit 3.2 to our Registration Statement on Form S-1, as amended (Registration No. 33-21353), and incorporated herein by reference).

*3.2    

Second Amended and Restated By-Laws of KCI

**10.1    

2003 Non-Employee Directors Stock Plan

*31.1    

Certification of Chief Executive Officer

*31.2    

Certification of Chief Financial Officer

   
 

  *Exhibit filed herewith.

 

**Management compensatory plan or agreement. Exhibit filed herewith.

 

 

       (b)   Reports on Form 8-K

             1.   Current Report on Form 8-K dated May 13, 2003. Regulation FD
                   disclosure including a press release detailing first quarter results for 2003.

 

Table of Contents

SIGNATURES

       Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

                                                                 KINETIC CONCEPTS, INC
                                                                 (REGISTRANT)

                                                                 By:   /s/ DENNERT O. WARE

Date: July 22, 2003                                  ______________________________
                                                                 Dennert O. Ware
                                                                 President and Chief Executive Officer

                                                                 By:   /s/ MARTIN J. LANDON

Date: July 22, 2003                                  ______________________________
                                                                 Martin J. Landon
                                                                 Vice President and Chief Financial Officer (Acting)

 

 

 

 

Table of Contents

Exhibit 31.1

CERTIFICATIONS

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

I, Dennert O. Ware, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Kinetic Concepts, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

   a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   c)   Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.   The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors:

   a)   All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

   b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: July 22, 2003

                                                              ___/s/ Dennert O. Ware____________
                                                              Dennert O. Ware
                                                              President and Chief Executive Officer

Table of Contents

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

I, Martin J. Landon, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Kinetic Concepts, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

   a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

   b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

   c)   Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.   The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors:

   a)   All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

   b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

 

Date: July 22, 2003

                                                          __/s/ Martin J. Landon________
                                                          Martin J. Landon
                                                          Vice President and Chief Financial Officer (Acting)